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5ABSTRACT
The effects of fat substitution on plasma fatty acid composition, serum lipid 
levels and plasma lipid classes were investigated in two studies comprising a 
total of 100 and 48 subjects, respectively. The analytical methods included 
gas chromatography (GC) of total plasma and plasma phospholipid (PL) fatty
acids, including octadecenoic trans-isomers. A high performance liquid
chromatographic method using evaporative light-scattering detection (HPLC-
ELSD) was applied for the quantitation of lipid classes. 
Substitute fats included canola-type, ordinary or cold-pressed rapeseed oils 
containing ca 11% α-linolenic (α-LLA) and 23% linoleic (LA) acids, a test 
margarine, and olive and soybean oils. The average daily doses in the groups 
during the six-week substitutions, designed to replace butter or margarine 
on bread, ranged from 14 to 23 g (15-22% of total fat intake). 
The results demonstrate a preference for n-3 polyunsaturated fatty acid
(PUFA) metabolism from α-LLA to longer-chain n-3 PUFAs over LA and n-6 
PUFA metabolism. This was most completely evident in plasma PL, when
butter was replaced by rapeseed oil, as a simultaneous fall in saturated fatty
acid (SaFA) and serum LDL cholesterol levels. The effect of monounsaturated 
oleic acid (n-9 MUFA), the main fatty acid in rapeseed oil (60%), remained 
neutral showing no increase in PL. The changes in PL followed the order of
competition between the unsaturated fatty acid families: (n-3) > (n-6) > (n-9). 
The increase in n-3 PUFAs was predominant at three weeks, while that in
n-6 PUFAs was highest at six weeks, without suppressing n-3 PUFAs. This
delay is in line with higher desaturase selectivity for α-LLA conversion to
long-chain n-3 PUFAs, and with their suppressive effect on n-6 PUFAs. The
test margarine (3% α-LLA; 28% LA) lacked an n-3 PUFA effect, and an
increase in PL LA (n-6) was seen already after the first three weeks. 
Replacement of margarines by rapeseed oil first reduced both PL SaFAs and 
n-6 PUFAs, but simultaneously raised n-3 PUFAs and MUFAs. Oleic acid in
dietary fat is thus a good counterpart with α-LLA. The amount of LA in the 
diet is in the key position during competition, since the rise in n-6 PUFAs at 
six weeks suppressed both n-3 PUFAs and MUFAs. Olive oil, instead of 
raising PUFAs, reduced LA levels in margarine users, which is desirable if 
the LA intake is high. However, due to the low α-LLA (<1%) and LA (<8%)
contents, olive oil is a poor source of essential fatty acids for high SaFA diet. 
Moderate amounts of α-LLA and LA, and a ratio of 1:2 in rapeseed oil, is
close to the optimum for the progress of competitive mechanisms in both n-3
and n-6 PUFA metabolism, with a priority for n-3 PUFAs over n-6 PUFAs. 
Rapeseed oil should be a permanent constituent of daily food in western-type 
diets in order to replace excessive intake of SaFAs, to lower cholesterol 
levels, to moderate LA intake, and to ensure an essential fatty acid balance 
using one and the same vegetable oil. The preference of n-3 PUFAs and n-3
eicosanoids can be expected to provide protective effects against coronary 
heart disease in particular, as well as against many other diseases which 
may be caused by long-term imbalances of essential fatty acids in the diet.
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7ABBREVIATIONS
AA arachidonic acid (20:4n-6)
ACAT acyl-coenzyme A-cholesterol acyltransferase
AgNO3-TLC silver nitrate thin-layer chromatography
α-LLA alpha-linolenic acid (18:3n-3)
BF3 bortrifluoride
BMI body mass index (kg/m2)
CAD coronary artery disease
CE cholesteryl ester
CETP cholesteryl ester transfer protein
CHD coronary heart disease
CLA conjugated linoleic acid
CM chylomicron
DHA docosahexaenoic acid (22:6n-3)
DPA docosapentaenoic acid (22:5n-3)
EFA essential fatty acid 
ELSD evaporative light-scattering detector
EPA eicosapentaenoic acid (20:5n-3)
FAME fatty acid methyl ester
FC free (unesterified) cholesterol
FFA free fatty acid
FID flame ionization detector
FTIR Fourier transform infrared spectroscopy
GC-MS gas chromatography-mass spectrometry
HDL high-density lipoprotein
HGLA homogamma-linolenic acid (20:3n-6)
HMG-CoA β-hydroxy-β-methylglutaryl-coenzyme A 
HPLC high performance liquid chromatography
HUFA highly unsaturated fatty acid (?C20 with ?3 double bonds)
IDL intermediate density lipoprotein
IHD ischaemic heart disease
LA linoleic acid (18:2n-6)
LCAT lecithin-cholesterol acyltransferase
LC-MS liquid chromatography-mass spectrometry
LDL low-density lipoprotein
LT leukotriene
MI myocardial infarction
MUFA monounsaturated fatty acid
NaOMe sodium methoxide
OA oleic acid (18:1n-9)
PC phosphatidyl choline
PG prostaglandin
PL phospholipid
PPP/PRP platelet poor/rich plasma
P/S ratio PUFA/SaFA ratio
PTV programmed temperature vaporizer
PUFA polyunsaturated fatty acid
RSD relative standard deviation
SaFA saturated fatty acid
SIM single ion monitoring 
sn stereospecific numbering
SPE solid phase extraction
TAG triacylglycerol
TC total cholesterol
TFA trans-fatty acid
TLC thin-layer chromatography
Tx thromboxane
VLDL very low-density lipoprotein
For fatty acids, see systematic names in the Appendix (p. 94). 
81. INTRODUCTION 
Fats in the food form a concentrated source of energy, and they carry fat-
soluble vitamins and provide essential fatty acids (EFAs) for further 
modification in the body. Stored fats provide most of the energy needed to 
fuel muscular work and to protect against temperature extremes. In
addition, the cellular plasma and organelle membranes within the human
body contain 40-80% lipids (Goodman 1994; Sizer and Whitney 1997). 
Differences in the effects of various types of fat led to the discovery of EFAs
already more than 70 years ago. In animal studies, Burr and Burr found 
that unsaturated fat is essential, and subsequently demonstrated that 
linoleic and linolenic acids are essential for growth and reproduction 
(Holman 1992). 
More detailed tissue fatty acid analyses became possible at the end of the 
1950s along with the development of gas chromatography (GC) (Horning et 
al., 1964; Holman and Rahm 1966). The basic features of polyunsaturated 
fatty acid (PUFA) metabolism could be verified from animal tissues using GC 
(Mead 1968; Holman 1968), and the mechanisms were shown to involve 
strong mutual competition between n-6 and n-3 PUFAs derived from linoleic
(LA, 18:2n-6) and α-linolenic (α-LLA, 18:3n-3) acids (Holman and Mohrhauer 
1963; Mohrhauer and Holman 1963). 
The two EFAs, LA and α-LLA, cannot be synthesized by the body, and they 
therefore have to be obtained from the diet. Edible plants are their original 
natural sources. Although most vegetable oils are rich in LA, only a few 
contain marked amounts of α-LLA (White 2000). EFAs are further converted 
to longer-chain n-6 and n-3 PUFAs, some of which, in turn, form their own 
series of eicosanoids (Sprecher 1981; Crawford 1983). Eicosanoids are found 
in very low quantities in human tissues, but they possess a number of
diverse effects especially in the cardiovascular system and inflammatory 
processes (Moncada and Vane 1979; Hwang 2000). Imbalances of EFAs are
additionally known to be related to many diseases (Chapkin 2000). 
9LA-rich oils have been considered to be the only sources of PUFAs, while n-3
PUFAs have been ignored even though data supporting their importance
have been available for decades. Much of the α-LLA was hydrogenated away 
for technical reasons (Holman 1998). In contrast, hardening also produces 
trans-fatty acids, which in abundance are assumed to have adverse health 
effects (Kris-Etherton 1995; Craig-Schmidt and Holzer 2000). 
In the early 1970s, middle-aged Finnish men had the highest mortality from 
coronary heart disease (CHD) in the world (Nikkari 1986; Vartiainen et al., 
1994). At that time, dietary fat with high saturated fatty acid (SaFA) and low
LA level resulted in a very low PUFA/SaFA ratio in the diet (Trygg 1991). In 
East Finland, a sharp decline in ischaemic heart disease (IHD) mortality
occurred during 1972-92 in a programme to lower the main risk factors -
high serum cholesterol (TC), high blood pressure and smoking - including a
substantial change in dietary fat, i.e. from butter to vegetable fats. Almost
half of the decline was related to the decrease in TC levels (Vartiainen et al., 
1994). However, some reviews have pointed out that the link between serum 
cholesterol and CHD is not always clear (Gurr 1992; Bruckner 2000).
Increasing attention is being paid to the anti-inflammatory, antithrombotic
and antiarrhythmic properties of long-chain n-3 PUFAs and cardiovascular 
disease (Leaf and Kang 1998; Lands 2003). A recent study shows that higher
proportions of these PUFAs in tissues indicate association with lower CHD 
mortality rates (Lands 2003). Diet enriched with α-LLA has also been found 
beneficial in the secondary prevention of CHD (de Lorgeril et al., 1994). 
This thesis is based on studies on the effects of fat replacement on serum
lipids, plasma lipid classes and fatty acid composition in habitual butter and
margarine users. The substitute fats included vegetable oils and a test 
margarine containing varying amounts of LA and α-LLA. This study focuses 
on analytical methods, fatty acid indicators during fat replacement, the 
metabolism of LA and α-LLA, and competitive interactions between n-6 and 
n-3 PUFAs at the plasma phospholipid (PL) fatty acid level. The importance
of effective amounts of EFAs in the diet is specifically discussed. 
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2. REVIEW OF THE LITERATURE 
2.1. Analysis of fatty acids and lipids 
Lipids are major constituents in plants and animals and form usually the 
main structural components of tissues. They can be classified into simple, 
complex and derived lipids which are sparingly soluble or insoluble in water,
but soluble in organic solvents. Their features are mainly determined by 
their constituent fatty acids, which differ in chain length, degree of
unsaturation, configuration, double bond positions and other functionalities 
(Thiele 1979; Shahidi and Wanasundara 1998). Methodologies in lipid and 
fatty acid analysis have been dealt with in the reviews mentioned below. 
Lipids are isolated by solvent extraction and separated and purified by thin-
layer chromatography (TLC) or solid phase extraction (SPE) (Kuksis and
Myher 1986; Myher and Kuksis 1995; Ruiz-Gutiérrez and Barron 1995;
Touchstone 1995). Silver ion TLC (AgNO3-TLC) is used to separate cis/trans
positional isomers of fatty acids (Lie Ken Jie 1980) and fatty acids with a 
different degree of unsaturation (Dudley and Anderson 1975).
Gas chromatography (GC) is the main technique in fatty acid analysis owing 
to its sensitivity, speed, high resolution and reproducibility. The basic GC 
methodology have been widely described recently (Shantha and Napolitano 
1992; Eder 1995; Gutnikov 1995; Ackman 2000a; Seppänen-Laakso et al., 
2002). In addition, high-temperature GC and GC-mass spectrometry (GC-
MS) are suitable for lipid profiling and for the determination of molecular
species of acylglycerols (Kuksis and Myher 1986; Myher and Kuksis 1995). 
High performance liquid chromatography (HPLC) is increasingly applied in
fatty acid (Gutnikov 1995; Brondz 2002; Lima and Abdalla 2002) and lipid 
analyses (Christie 1987; Myher and Kuksis 1995; Ruiz-Gutiérrez and Barron
1995). Evaporative light-scattering detector (ELSD) and MS detection by LC-
MS have significantly improved the quantitation and identification of lipid 
mixtures (Christie 1987; Myher and Kuksis 1995; Lima and Abdalla 2002). 
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2.1.1. Isolation and fractionation of lipids 
Pretreatment of the sample starts by selecting solvents and modes of lipid
extraction. The problem in total lipid extraction is twofold: some of the 
solvents are immiscible with water and some are poor solvents for polar
lipids (mostly phospholipids; PL) (Ruiz-Gutiérrez and Barron 1995; Ackman 
2000a). The traditional extraction by chloroform/methanol (2:1) including 
washing with a salt solution (Folch et al., 1957) is widely applied with 
modifications, e.g. one-step extraction using a ratio of 3:1 in excess of water 
(Chlouverakis and Hojnicki 1974). Another method still in use is that of
Bligh and Dyer (1959), in which the ratio of solvents is changed to improve 
extraction from tissues with a higher water content. 
Lipids in fatty oils and oilseeds that contain mainly triacylglycerols (TAGs)
have been commonly extracted with non-polar solvents such as petroleum
ether (Appelqvist 1968; Hiltunen et al., 1979), hexane (Shahidi and Wana-
sundara 1998), diethylether or chloroform (Ruiz-Gutiérrez and Barron 1995).
Food products such as shortenings, fish fillets, baby foods and beef have 
been extracted with various chloroform/methanol mixtures (Slover and
Lanza 1979; Lanza and Slover 1981; Sahasrabudhe and Smallbone 1983).
Human tissue lipids comprise complex mixtures containing a variety of lipid
classes of different polarities, i.e. TAGs, free fatty acids (FFAs), sterols (e.g. 
cholesterol), sterol esters, PLs, gangliosides, ceramides and sphingolipids, as 
well as non-lipid substances (Goodman 1994; Shahidi and Wanasundara 
1998). Plasma total lipid extraction is still based on chloroform/methanol 
(2:1) and (1:2), respectively (Folch et al., 1957; Bligh and Dyer 1959). 
A wide range of PLs can be fractionated into subclasses on a silica gel
column by increasing the methanol/chloroform ratio in the eluent from 1:6 
to 9:1, for example (Thiele 1979). Lipid classes from plasma, serum and 
plasma lipoproteins have been isolated on silica gel G plates (Moilanen and
Nikkari 1981; Sko?epa et al., 1983; Kovács et al., 1988). SPE is also effective 
in separating lipid classes of different polarity (Touchstone 1995). 
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2.1.2. Derivatization of fatty acids
The preparation of methyl esters (FAMEs) is the most common procedure 
before analysing fatty acids by GC. These methods and their advantages and 
disadvantages have been dealt with in detail (Shantha and Napolitano 1992;
Eder 1995; Gutnikov 1995). 
Methods for esterifying both lipid-bound and free fatty acids, such as direct 
esterification (HCl or H2SO4/MeOH), saponification-esterification (KOH, HCl/ 
MeOH) or boron trifluoride (BF3/MeOH) methods (Sheppard and Iverson 
1975), are still widely used. Esterification by BF3/MeOH has been applied for 
a variety of lipids (Bannon et al., 1982; Shantha and Napolitano 1992; Eder 
1995). Derivatization with HCl/MeOH has been used for cholesteryl ester 
(CE), TAG and PL fractions and FFAs from human serum (Moilanen and 
Nikkari 1981; Nikkari et al., 1983a), for cerebrospinal and amniotic fluid, 
plasma or serum, erythrocytes, leukocytes and neuroblastoma tissue
(Muskiet et al., 1983), and for plasma CE and TAGs (Hoving et al., 1988). 
Derivatization by sodium methoxide (NaOMe), which does not esterify FFAs, 
is a rapid method for bound fatty acids. A 2-5 min reaction time appears to 
be effective for the conversion of seed oil TAGs to FAMEs (Appelqvist 1968). 
Transesterification of the TLC-isolated PL fraction at 40°C for 5 min was 
found to be optimum without the formation of FFAs (Seppänen-Laakso et al.,
1990a). The method can be also used as the first step in removing fatty acids 
from sn-2 and sn-3 positions of alkylglyceryl ethers, after which free hydroxyl 
groups can be silylated (Seppänen-Laakso et al., 1990b). Fatty acids from 
CEs, TAGs and phosphatidyl choline (PC) from plasma and lipoprotein 
fractions have been derivatized by 0.5N NaOMe (Sko?epa et al., 1983). 
Amide-bound fatty acids from sphingomyelin, in turn, are not hydrolyzed
and derivatized by this procedure (Bittman and Verbicky 2000).
New applications of more specific derivatization techniques have been 
described in a number of reviews (Eder 1995; Hušek 1998; Ackman 2000a;
Seppänen-Laakso et al., 2002). 
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2.1.3. Separation of cis/trans-isomeric fractions
Trans-octadecenoic (18:1) acid isomers form the most abundant group of
trans-fatty acids in food fats and, together with cis-isomers, represent the 
most complicated samples in the analysis. Chromatographic separation of
these isomeric groups is therefore necessary before the identification of
individual isomers. 
Fatty acids are first esterified to FAMEs, and the separation of trans- from 
cis-isomers is then carried out on AgNO3-TLC plates (Lie Ken Jie 1980; 
Dobson et al., 1996; McDonald and Mossoba 1998). By using specific 
adducts, FAMEs can be fractionated according to the degree of unsaturation, 
and the cis- and trans-isomers then separated by AgNO3-TLC (Ratnayake
and Beare-Rogers 1990). Butyl or isopropyl esters can be also prepared 
instead of FAMEs before TLC isolation of the isomers (Ackman and 
Macpherson 1994; Chardigny et al., 1996). 
Silver ion HPLC columns have been increasingly used for the separation of
trans-fatty acids (Nikolova-Damyanova et al., 1992; Adlof 1994; Dobson et
al., 1996). Reversed-phase HPLC is also applied for the isolation of the group
of conjugated linoleic acid (CLA) isomers in FAME mixtures  (Lavillonnière et 
al., 1998; Hurst et al., 2001). 
In the determination of 18:1trans-isomeric profiles in a range of human 
tissues, the lipid classes have been first fractionated by TLC, and the cis-
and trans-FAMEs then separated by AgNO3-TLC (Ohlrogge et al., 1982). In
human studies dealing with the incorporation of deuterium-labeled palmitic, 
oleic and linoleic acids (Emken et al., 1989a) or trans-isomers (Emken et al., 
1989b), lipid classes have been separated by SPE or TLC, respectively, and 
then analysed by GC-MS. 
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2.1.4. Gas chromatography
The introduction of capillary columns marked the start of improved GC 
separation of fatty acid isomers (Ackman 1966; Ackman and Castell 1966). 
Later on, a number of liquid phases were applied in fatty acid analysis on 
glass capillary (Heckers et al., 1977; Hiltunen et al., 1979; Slover and Lanza 
1979; Lanza and Slover 1981; Muskiet et al., 1983; Bohov et al., 1984) and 
fused silica columns (Gillan 1983; Arrendale et al., 1983; Kramer et al., 
1985). Silica columns had better inertness, stability and resolution (Lipsky 
et al., 1980; Jennings 1980), and became highly applicable in practical work
due to their flexibility and simplicity to connect to GC and MS (Kaiser and 
Klee 1986). 
New sampling methods, such as cold on-column injection (Schomburg et al.,
1977; Grob and Grob 1978; Hiltunen et al., 1982) and programmed 
temperature vaporization (PTV) techniques (Poy et al., 1981; Schomburg et
al., 1983), markedly improved the accuracy and precision of analyses by
largely avoiding the problems due to the splitting system of the GC injector. 
The present-day GC technique has been dealt with in reviews covering 
injection methods, optimization of GC parameters, the liquid phases of
columns, isomeric fatty acid analyses, identification including GC-MS,
quantification and applications in food and human tissue fatty acid analyses 
(Shantha and Napolitano 1992; Eder 1995; Gutnikov 1995; McDonald and 
Mossoba 1998; Ackman 2000a; Seppänen-Laakso et al., 2002). 
Reproducibility. In capillary GC, normalized peak areas should be 
reproducible (<1%, RSD) (Yang et al., 1978) and, in practice, this is well 
achievable for main fatty acids, for example in the analysis of oilseeds and
vegetable oils (Hiltunen et al., 1982; Caplan and Cronin 1983). For minor
fatty acids (<0.5%), however, the values can be clearly higher (10-20%, RSD).
The conventional split sampling mode, i.e. sample injection into a hot 
injector, is widely used in routine analysis, and the precision can be 
markedly improved by means of automatic sampling (Bannon et al., 1987). 
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The precision and accuracy attainable by the cold on-column technique are 
superior to those with conventional GC injection, and the analysis of minor
fatty acids, in particular, becomes much more reliable (<5%, RSD) (Hiltunen 
et al., 1982; Badings and de Jong 1983; Geeraert et al., 1983; Eder 1995). 
The PTV injection modes, some of which are especially intended for dilute 
samples, are reproducible techniques (Eder 1995), and have proved to be
especially suitable in the fatty acid analysis of plasma lipid fractions 
(Seppänen-Laakso et al., 2002). 
Analysis and identification. Most of the separation problems in GC analysis 
are caused by fat mixtures containing 18:1trans-fatty acids, and therefore
trans-isomers have to be separated from cis, as described in (2.1.3.). The cis-
or trans-double bond positions have been traditionally determined by 
degradative methods such as ozonolysis, followed by identification of the
derivatized products by GC or GC-MS (Ackman and Castell 1966; Ackman 
1977; Thiele 1979; Sebedio et al., 1981; Fell and Schäfer 1991). 
Trans-fatty acid analysis is useful for recognizing sources of fat in food 
products, as well as for profiling trans-isomeric patterns in tissues. For 
example, in the determination of trans-fatty acids in French fries, carried out
by AgNO3-TLC, ozonolysis and GC or GC-MS, marked contents of 18:1trans-
isomers indicated the use of hydrogenated vegetable oils as the source of fat
(Sebedio et al., 1994). Similarly, the 18:1trans-fatty acids of French infant 
formulae were characterized by vaccenic acid (18:1n-7trans) indicative of 
bovine milk, while di- and trienoic trans-PUFAs were similar to those in 
deodorized oils (Chardigny et al., 1996). The methods can be also applied in 
determining 18:1trans-distributions in human tissue PLs (Rocquelin et al., 
1989).
Fatty acid methyl esters analysed on a specific stationary phase can be
tentatively identified on the basis of standards, known composition of fats or, 
alternatively, by using the relative retention times of FAMEs vs reference
FAMEs or equivalent chain length values. However, identification must be
confirmed by on-line MS (Eder 1995). 
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The use of long capillary columns (30-100 m) and new phases markedly 
improved the separation (Jaeger et. al., 1975) and they have been frequently
used in both food (Slover and Lanza 1979; Lanza and Slover 1981) and 
human tissue fatty acid analysis (Heckers et al., 1977; Bohov et al., 1984).
For example, these columns enabled the determination of all four LA isomers 
(9cis,12cis-18:2, 9trans,12cis-18:2, 9cis,12trans-18:2, 9trans,12trans-18:2)
in both foods (Lanza and Slover 1981) and human serum (Bohov et al., 
1984; Krup?ik and Bohov 1985). 
Excellent resolution can be achieved on present-day long capillary columns
in the direct analysis of a wide range of cis-isomeric fatty acids. Most of the
menhaden oil fatty acids, for example, can be separated and identified by an
isothermal GC run (Ackman 2000a). The resolution of the series of 18:1trans
isomers in edible fats can be improved by lowering the GC oven temperature 
and by increasing the inlet pressure of the carrier gas. The modifications 
resulted in similar trans-fatty acid contents analysed either by AgNO3-
TLC/GC or by the direct GC method (Molkentin and Precht 1995). 
Besides MS, other spectroscopic methods and specific fatty acid derivatives 
(Ratnayake and Beare-Rogers 1990) have been applied in the analysis of food 
fats. In the determination of trans-isomers in margarines the content of total
trans-isomers has been quantified by infrared (IR) spectroscopy (Ratnayake
et al., 1990). Identification using Fourier transform IR (FTIR) detector has
been applied in the analysis of partially hydrogenated fats (Mossoba et al., 
1990, 1993).
CLA isomers (e.g. 9cis,11trans-18:2) in cheese and milk chocolate can be 
identified as dimethyloxazoline derivatives (Hurst et al., 2001; Lavillonnière
et al., 1998), and as FAMEs in a number of foods (Fritsche and Steinhart
1998), by using GC-MS and GC-FTIR. Both picolinyl esters and dimethyl-
oxazoline derivatives have been applied in the identification of trans-fatty
acids, including CLA isomers, by GC (Lavillonnière et al., 1998) or by MS 
(McDonald and Mossoba 1998; Hurst et al., 2001). 
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2.1.5. High performance liquid chromatography
The use of HPLC has become an important means of lipid analysis. The
problems related to sensitivity in the detection and quantitation of non-
chromogenic lipids by UV light have been largely overcome after developing 
ELSD (Christie 1987; Myher and Kuksis 1995). It is highly applicable for
profiling and quantitative analysis of lipid classes of different polarities in
tissue extracts (Christie 1985, 1986; Lutzke and Braughler 1990; Markello et 
al., 1991; Picchioni et al., 1996; Homan and Anderson 1998). Identification 
of lipids by LC-MS is useful for complex mixtures (Myher and Kuksis 1995). 
Proper resolution of the analyses, usually carried out on silica columns, 
provides gradient elution from non-polar to polar solvents and careful re-
equilibration of the chromatographic system. For quantitation it is necessary
to calibrate lipid classes separately due to the high differences in responses 
(Christie 1985; Lutzke and Braughler 1990; Homan and Anderson 1998). 
Plasma lipid classes. In humans, the cholesterol-containing lipid classes are 
dominant in the low-density lipoproteins (LDL), especially. CEs are carried in 
the core of lipoprotein particles, while free cholesterol (FC), PLs and apo-
proteins are constituents of their outer monolayer (Eisenberg 1984; Voet and 
Voet 1995). A high proportion of PC, a subfraction of PLs, is typical for the
high-density lipoprotein (HDL) fraction (Hemming and Hawthorne 1996). PC
is rich in PUFAs and its sn-2 position is characterized by a high proportion
of LA, which is utilized by the HDL-associated lecithin-cholesterol acyl 
transferase (LCAT) to esterify FC to CE (Eisenberg 1984; Jonas 1987; Voet 
and Voet 1995). A major part of the plasma cholesterol is esterified with fatty 
acids, mainly LA, and FC represents about 30% of the total cholesterol
concentration (Vercaemst et al., 1989). 
Analysis of lipid class composition by ELSD has been applied to several
human tissue cell cultures and biopsy specimens (Markello et al., 1991), and 
animal tissue extracts (Homan and Anderson 1998). 
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2.2. Fatty acid composition of dietary fats 
A variety of oils from plants (Hunter 1990; White 2000; Kris-Etherton et al., 
2000) and fish (Hearn et al. 1987; Ratnayake et al., 1988; Kris-Etherton et 
al., 2000; Ackman 2000b) provide the most significant sources of EFAs and 
other PUFAs for the diet. In addition, vegetable oils have, almost without
exception, the lowest SaFA contents. The fatty acid composition of major oils 
and fats are given below. 
2.2.1. Vegetable oils 
Vegetable oils are 100% fat and they have distinct fatty acid compositions,
(Table 1) which can be roughly classified as high linoleic (LA>50%), oleic
(OA>50%) and SaFA oils (about 50%). The principal sources of α-LLA are 
rapeseed (canola; 11%) and soybean oils (7%) (Hunter 1990). Other oils 
usually contain α-LLA below 1% and also have markedly higher LA/α-LLA
ratios.
Table 1. Main fatty acid composition and vitamin E contents of common
 vegetable oils.
__________________________________________________________________________________________
Fatty acids Sunflower Corn Palm Olive Soybean Rapeseed
 (%) 1) 2) 1) 3)
__________________________________________________________________________________________
Total SaFAs 12.6 14.5 51.4 17.1 13.3 15.4 6.8 5.6
16:0 Palmitic acid 6.8 12.2 45.1 13.7  9.4 11.0 3.9 3.3
18:0 Stearic acid 4.7 2.2 4.7 4.0  3.0 4.0 1.9 1.5
Total MUFAs 18.7 27.6 38.9 72.3 78.3 23.5 65.3 59.6
18:1 Oleic acid 18.6 27.5 38.8 71.1 77.4 23.4 64.1 57.0
Total PUFAs 68.7 57.9 9.7 10.6 8.4 61.0 27.9 34.8
Linoleic acid (n-6) 68.2 57.0 9.4 10.0 7.5 53.2 18.7 23.5
 α-Linolenic acid (n-3) 0.5 0.9 0.3 0.6 0.8 7.8 9.2 11.2
LA / α-LLA ratio 136 63 31 17 9 7 2 2
__________________________________________________________________________________________
Vitamin E (mg/100g) 4 63.4 34.2 8.4 12.0 17.3 23.8
__________________________________________________________________________________________
1 White 2000; zero-erucic acid (canola-type) rapeseed oil from rape (Brassica napus L.)
and turnip rape cultivars (B. campestris L.).
2 Seppänen-Laakso et al., 1993a. 
3 Canola-type rapeseed oil from B. campestris L. (Seppänen-Laakso et al., 1992).
4 Anon. 2003a (Food Composition Database Fineli®, http://www.ktl.fi).
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2.2.2. Fish and other seafoods 
Comprehensive data on the fatty acid composition of fish species and oils
therefrom, and on other seafoods, have been given by Hearn et al. (1987) and 
Ackman (2000b). Marine foods are rich in long-chain n-3 PUFAs, especially
eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids (Table 2). Some 
fish oil concentrates can even have EPA and DHA contents of up to 20-35 
and 25-50%, respectively (Ratnayake et al., 1988). 
Table 2. Fatty acid composition and fat contents of common fish species. 
_________________________________________________________________________________________
Fatty acids Herring Mackerel Pike Sardines Rainbow Ocean Tuna Pink
 (%)1,2 trout trout salmon
__________________________________________________________________________________________
Total SaFAs 24.2 27.3 14.6 24.1 23.4 28.8 20.5 19.3
 16:0 16.5 17.5 6.6 14.5 11.4 19.1 9.5 13.0
 18:0 2.6 5.8 3.6 4.9 7.3 8.0 7.9 3.0
Total MUFAs 43.4 21.0 29.7 29.2 26.5 15.6 30.1 25.3
 16:1 8.9 6.0 5.7 7.0 8.2 3.3 7.5 5.2
 18:1 18.1 7.8 6.8 15.4 17.4 9.9 17.5 14.0
 20:1 7.1 4.1 13.6 4.2 - 1.6 2.6 3.5
Total n-6 PUFAs 1.8 9.6 23.1 3.7 13.7 7.1 8.0 6.8
 18:2n-6, LA 1.8 1.9 3.1 1.4 12.3 1.3 1.8 2.0
 20:4n-6, AA - 6.9 20.0 0.9 1.4 4.1 4.1 2.8
Total n-3 PUFAs 23.6 41.2 29.8 43.4 30.1 48.0 37.6 39.9
 18:4n-3 2.9 2.4 4.6 3.8 2.1 - 1.2 4.2
 20:5n-3, EPA 9.2 11.2 7.5 11.3 5.1 6.7 7.5 11.0
 22:5n-3 1.8 4.1 2.5 2.5 2.6 2.0 2.5 3.1
 22:6n-3, DHA 8.9 22.8 15.2 25.8 16.8 39.3 26.4 20.0
__________________________________________________________________________________________
Fat (g/100g)2 12.0 20.6 0.91 9.7 1.8 1.4 7.5 4.21
__________________________________________________________________________________________
1 Hearn et al., 1987; 2 Ackman 2000b
Fish such as herring, mackerel, sardines, tuna, salmon and sturgeon are 
considered to be oily fishes (Ackman 2000b). The fat content of cod, on the 
other hand, is below 1% but contains 15% of EPA and 30% DHA (Hearn et 
al., 1987). In a number of more exotic seafoods like oysters, mussels,
shrimps, scallops and lobsters the amount of fat ranges between 1-2.5%, but
with marked proportions of EPA (7-20%) and DHA (6-18%) (Ackman 2000b). 
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2.2.3. Margarines and spreads 
Margarines and spreads used on bread are major sources of dietary fats.
They contain 28-80% of fat derived from vegetable oils and other vegetable
fats, part of which can be hardened (Anon. 2003b). However, no exact 
composition can be given for majority of these fats due to their highly varying 
contents of SaFAs, MUFAs and PUFAs (Table 3). The composition (%) of fat
was calculated from data in which the fatty acid contents (incl. trans) were 
given as g/100g product (Anon. 2003b). Rapeseed oil was an ingredient in
most of the products, and the n-6/n-3 PUFA ratio was given in some cases. 
Table 3. Fatty acid composition of margarines and spreads. 
__________________________________________________________________________________________
Fatty acids Common German margarines1 Finnish margarines and spreads
 (%) 1994 1999 19882 20033 20034
__________________________________________________________________________________________
Total SaFAs 21.0 29.2 13.8-57.7 24.1 20.0-27.5 15.6-42.9
 16:0 8.1 9.6 10.8
 18:0 11.3 16.8 7.8
Total MUFAs 44.3 24.5 20.8-33.9 40.1 30.0-50.0 25.7-56.3
 18:1n-9cis 23.1 19.3 31.1
 18:1trans 20.7 4.9 1.8-5.6 8.1 < 1.3-2.9 < 1.3-3.6
Total PUFAs 34.5 46.2 21.8-55.1 35.8 25.0-50.0 14.3-48.6
 18:2n-6, LA 33.2 45.4 33.5 15.0-44.2
 18:3n-3, α-LLA 0.3 0.3 2.2 5.7-8.6
LA (n-6)/α-LLA (n-3) 111 151 15 2.0-7.6
__________________________________________________________________________________________
1 German sunflower margarines (Precht and Molkentin 2000).
2 Mean of 5 common margarines (Seppänen-Laakso et al., 1993a).
3 Range of 7 products, n-3 and n-6 PUFAs reported, fat content 35-80% (Anon. 2003b,
http://www.margariinitiedotus.fi).
4 Range of 16 products, fat content 28-80%, no data on n-3 and n-6 PUFA contents,
3 products contain stanolesters 8g/100g (Anon. 2003b).
3,4 Fatty acid composition calculated from Anon. 2003b and normalized to 100%.
An overall decreasing trend in trans-fatty acid contents in these fats is clear 
during the last decade (Table 3). New techniques, i.e. interesterification of 
liquid oils with SaFAs, is used as an alternative to hydrogenation in order to 
produce low-trans or trans-free margarines (deMan 2000). However, some
fats can contain unexpectedly high proportions of SaFAs (>40%); this was
even the case for two fats belonging to the low-fat spreads (28-40% fat). 
21
2.2.4. Butter 
The fatty acid composition of bovine milk (~3.5% fat) and butter (80% fat) 
(Table 4) are characterized by a high content of SaFAs (65-70%), about 20-
30% of MUFAs (Jensen 2000), and a discernible profile of 18:1trans-isomers
accounting for 2-6% of the total fatty acids (Ackman and Macpherson 1994; 
Kris-Etherton 1995; Craig-Schmidt and Holzer 2000). Oleic acid is the main 
MUFA, accompanied by cis-vaccenic acid and vaccenic acid (18:1n-7trans) as 
the most abundant trans-isomer (Ackman and Macpherson 1994). Butter/
vegetable oil (rapeseed oil) mixtures (fat content 40%) can contain 9% LA and 
5% α-LLA (Table 4). 
Table 4. Fatty acid composition of milk fat and butter. 
__________________________________________________________________________________________
Fatty acids Milk1 German Butter3 French Finnish butter Butter-
 (%) milks2 butter4 5) 6) vegetable oil7
__________________________________________________________________________________________
Total SaFAs 64.9 63.5 62.3 69.9 69.7 67.5 44.4
 10:0-14:0 18.1 17.6 17.0 19.6 19.7 18.1 10.8
16:0 29.9 28.6 26.2 33.3 36.0 26.1 17.5
18:0 9.7 9.5 10.8 9.0 13.8 11.1 8.1
Total MUFAs 32.4 25.2 26.2 20.6 28.1 26.7 37.9
 16:1n-7 3.3 1.6 1.7 0.3 1.6 1.3 0.8
 18:1 cis 26.5 23.6 24.1 19.2 24.3 23.1 35.5
 18:1 trans 2.4 1.9 2.3 1.6
Total PUFAs 2.8 1.9 2.4 1.7 2.2 1.9 14.1
 18:2n-6, LA 2.8 1.2 2.4 1.4 1.7 1.3 9.5
 18:3n-3, α-LLA 0.7 0.3 0.5 0.4 0.6 4.6
__________________________________________________________________________________________
1 U.S. Bovine milk, in February, Jensen 2000; 2 Precht and Molkentin 1997.
3 Iverson and Sheppard 1986; 4 French butters, in January, Wolff et al., 1995.
5 Finnish butter, 4:0-8:0 fatty acids not included, Seppänen-Laakso et al., 1992.
6 summer butter, Aro 1991; 7 butter-rapeseed oil mixture, fat content 40%, Aro 1991. 
The cholesterol contents of milk and butter fat are 150 mg/L and about
2 g/kg, respectively (Sizer and Whitney 1997; Jensen 2000). In addition,
dairy products contain a large number of other minor fatty acids, such as 
CLA-isomers, of which 9cis,11trans-18:2, especially, is considered to be 
bioactive (Lavillonnière et al., 1998; Fritsche and Steinhart 1998; Craig-
Schmidt and Holzer 2000; Jensen 2000). 
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2.3. Essential fatty acid metabolism 
2.3.1. Conversion of linoleic and α-linolenic acids up to eicosanoids
Dietary LA and α-LLA are the parent EFAs forming the two non-inter-
convertible PUFA families. The same elongating and desaturating enzymes 
convert them to longer-chain n-6 and n-3 PUFAs (Sprecher 1981, 1992; 
Sprecher et al., 1995). Of these, homogamma-linolenic acid (HGLA), 
arachidonic acid (AA) and EPA act as the precursors of different eicosanoids 
(Fig. 1) (Sprecher 1981; Crawford 1983; Hwang 2000). 
Linoleic acid 
18:2n-6
α- Linolenic
acid 18:3n-3
GLA
18:3n-6
HGLA
20:3n-6
AA
20:4n-6
18:4n-3
DPA 22:5n-3
DHA
22:6n-3
22:4n-6
22:5n-6
20:4n-3
∆6-
desaturase
∆5-
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24:5n-3
24:6n-3
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24:4n-6
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20:5n-3
PGE3, PGF3, PGD3
∆17Prostacyclin
TxA3
LTA5, LTB5, LTC5
PGE1, PGF1
TxA1
LTA3, LTC3, LTD3
PGE2, PGF2, PGD2
Prostacyclin
TxA2
LTA4, LTB4, LTC4
LTD4, LTE4
β-oxidation β-oxidation
Elongase β-oxidation
Fig. 1. Metabolic pathways of essential fatty acids. Eicosanoids are shown in
  dotted boxes.
Once ingested, LA and α-LLA are metabolized mainly in liver microsomes. In
the first step, a double bond is introduced by ∆6-desaturase to position 6 of 
the carbon chain. The chain elongation up to C20 and desaturation at 
position 5 produces HGLA and AA, respectively, which are the eicosanoid
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precursors of the linoleate (n-6) family. Correspondingly, EPA formed by ∆5-
desaturase acts as the eicosanoid precursor of the linolenate (n-3) family 
(Sprecher 1981; Crawford 1983). Thus, equal number of steps are required 
for the formation of AA and EPA from their dietary precursors.
The long-chain PUFAs, i.e. HGLA, AA and EPA, form their own series of 
prostaglandins (PG) and thromboxanes (Tx) via cyclo-oxygenase and 
leukotrienes (LT) via lipoxygenase pathway, respectively (Crawford 1983). 
Substrate availability is a limiting factor and therefore the precursor fatty
acids have to be incorporated into tissue PLs and cleaved as FFAs by 
phospholipases before initiation of the synthesis (Hwang 2000). The kinds of
eicosanoid synthesized vary with the type of tissue and when and where the 
cells are stimulated. Eicosanoids are not stored in cells but rapidly 
metabolized, and thus their effects are locally expressed. 
Docosahexaenoic acid (DHA, 22:6n-3) is the most highly unsaturated fatty 
acyl constituent in all cell membranes possessing marked functions in
retinal and neuronal tissues, especially (Stubbs 1992; Bazan et al., 1992). 
However, the metabolic pathway is not yet fully clear, since direct synthesis
from EPA to DHA via docosapentaenoic acid (DPA, 22:5n-3) does not occur 
in microsomes due to the lack of ∆4-desaturase. A pathway, in which DPA is 
rather elongated to 24:5n-3 and then to 24:6n-3 by ∆6-desaturase finally 
forming DHA in peroxisomes by β-oxidation (Fig. 1), is assumed to be the
primary mechanism (Sprecher 1992; Sprecher et al., 1995). This also
includes a retroconversion from DHA to EPA, that occurs especially after 
EPA-free intake of DHA (von Schacky and Weber 1985; Conquer and Holub
1997; Nelson et al., 1997). 
The metabolism of dietary LA and α-LLA utilizes the same enzyme systems, 
which indicates that continuous competition takes place between the two 
PUFA families. To take advantage of this competition is considered to be 
important for modulating eicosanoid biosynthesis through changes in the 
composition of dietary fatty acids (Crawford 1983; Holman 1986; Lands et 
al., 1992; Hwang 2000). 
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2.3.2. Competition between unsaturated fatty acid families 
The traditional studies performed on animal tissues in the 1960s by GC 
confirmed the basic properties of EFA metabolism. The conversion of LA 
(18:2n-6) to AA (20:4n-6) was found to be inhibited by dietary α-LLA
(18:3n-3) in rat tissue lipids (Mohrhauer and Holman 1963), and dietary LA 
suppressed the levels of the metabolites of α-LLA (Rahm and Holman 1964). 
A hypothesis was then presented, according to which the metabolic pathway 
of chain lengthening and dehydrogenation obviously favours the substrates
in the order α-LLA (n-3) > LA (n-6) > OA (n-9) (Holman and Mohrhauer
1963). Therefore, the pattern of PUFAs in tissue lipids is controlled by the 
concentrations of competing substrates in a common metabolic pathway.
Competition between n-6 and n-3 fatty acids, occurring at the level of
desaturation and chain elongation, has been demonstrated in a variety of in
vivo and in vitro experimental models. With the ∆6-desaturase enzyme, α-LLA
is a better substrate than LA (Cook 1991). Simultaneous feeding of deuter-
ated LA and α-LLA has shown that the conversion of α-LLA to n-3 PUFA 
metabolites (EPA and DHA) is much greater than that of LA to n-6 longer 
chain PUFAs in man (Emken et al., 1992). 
Later on, it was confirmed that the mixture of longer-chain (C20-C22) PUFAs
maintained in the PLs of human plasma is related to the dietary intake of LA 
and α-LLA by empirical hyperbolic equations in a manner very similar to the
relationship reported for rats. In addition, competition between the n-3 and 
n-6 PUFAs can diminish the abundance of eicosanoid precursors in tissues 
which, in turn, can diminish the intensity of tissue responses that are 
mediated by n-6 eicosanoids (Lands et al., 1992; Lands 2000).
The essential PUFAs, LA and α-LLA, in contrast, are maintained in tissue 
TAGs in a linear relation to their average dietary supply (Lands 1995, 2000).
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2.3.3. Polyunsaturated fatty acid metabolism modulated by diseases
Abnormal fatty acid patterns in human serum, especially those of n-6
PUFAs, have been long known in several diseases. PUFA alterations can be 
caused either by dietary insufficiency of LA or its abnormal metabolism 
(Holman and Johnson 1981). Disorders, like cystic fibrosis, Crohn's disease, 
Sjögren-Larsson syndrome and congenital liver disease, have reduced
capabilities for desaturation or chain elongation. Alcoholism, cirrhosis, 
Reye's syndrome and chronic malnutrition are also accompanied by 
abnormal PUFA profiles in serum PLs (Holman 1986, 1998; Cook 1991).
Research during the last decades has largely increased our knowledge of the 
metabolism of EFAs and the importance of the balance between longer-chain 
n-6 and n-3 PUFAs. The effects of eicosanoids on immune responses in a 
number of diseases, in particular, has become the topic of widespread 
research (Klurfeld 1998; Boissonneault 2000). Major abnormalities in 
diabetes are hyperglycemia and dyslipidemia, showing altered fatty acid
metabolism. The desaturases responsible for the synthesis of PUFAs are 
decreased, leading to more SaFAs and less PUFAs, especially AA, in tissue 
PLs and other lipids. In addition, membrane fluidity is altered (Bhathena 
2000). Some eicosanoids such as leukotriene LTB4 derived from AA (20:4n-6) 
are potent mediators of inflammation in diseases such as arthritis and
psoriasis. In order to reduce inflammatory symptoms by altering the n-6/n-3 
PUFA ratio, inhibition by fish oil n-3 fatty acids, in particular, suggests
desirable effects (Cleland et al., 1992; Boissonneault 2000).
The effects of DHA include the improvement of visual dysfunctions of the 
retina caused originally by an inadequate intake of n-3 PUFAs (Hoffman 
2000). In dietary α-LLA deficiency, neurological symptoms were ameliorated 
after α-LLA supply and an increase in DHA in serum PLs (Holman et al., 
1982). There is further evidence that schizophrenic and depressive patients 
have lower n-6 and/or n-3 membrane PUFA levels in association with
symptom severity. In these cases, balanced EFA diets with a high intake of 
fish and vegetables had especially beneficial effects (Yao and Reddy 2000). 
26
2.4. Lipoprotein metabolism 
TAGs, which constitute about 90% of the dietary fat, are the principal form 
of metabolic energy storage. Fat digestion and absorption take place mainly 
in the small intestine, where lipases release fatty acids enhanced by the 
emulsifying bile acids (Voet and Voet 1995). The lipolytic products, together 
with the bile salts, form micelles which are mainly taken up by passive 
diffusion by the microvilli of the enterocytes. Then they are re-esterified and 
packaged into chylomicrons (CMs), that are soluble in an aqueous medium. 
CMs consist of a non-polar core containing TAGs and a variable amount of
CEs that is covered by a surface coat of PLs, FC and apolipoproteins.
Table 5. Composition of human plasma lipoproteins (Voet and Voet 1995). 
__________________________________________________________________________________________
Lipid and protein constituents (g/L)
___________________________________________ Major apolipoproteins present
 FC CE TAG PL Protein
__________________________________________________________________________________________
CM 1-3 3-5 84-89 7-9 1.5-2.5 A-I, A-II, B-48, C-1, C-II, C-III, E 
VLDL 5-10 10-15 50-65 15-20 5-10 B-100, C-I, C-II, C-III, E
IDL 8 30 22 22 15-20 B-100, C-III, E
LDL  7-10 35-40  7-10 15-20 20-25 B-100
HDL 3-4 12 3-5 20-35 40-55 A-I, A-II, C-1, C-II, C-III, D, E 
__________________________________________________________________________________________
Densities (g/cm3): chylomicrons (CM; <0.95), very low density lipoproteins (VLDL; <1.006),
intermediate density lipoproteins (IDL; 1.006-1.019), low density lipoproteins (LDL; 1.019-
1.063) and high density lipoproteins (HDL; 1.063-1.210).
In the following step, CMs deliver TAGs to muscle cells or adipose tissue, 
and absorbed cholesterol to the liver. When CMs come into contact with the 
capillary endothelium of blood vessels, the lipoprotein lipase activated by
apolipoprotein C-II hydrolyzes the TAGs from the CMs. The FFAs then enter 
muscle cells or adipocytes, where they are again re-esterified to TAGs or 
oxidized (Mensink et al., 2000). After delivering TAGs, the core of CM
shrinks, and some of the protein, PLs and FC are transferred to HDL 
particles. The cholesterol-enriched CM remnant then binds to the LDL-
apoprotein B-receptor and other hepatic receptors, and is catabolized in the
liver. Cholesterol is esterified by acyl-CoA-cholesterol acyltransferase (ACAT)
and temporarily stored as CEs (Dietschy 1997). 
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Cholesterol synthesized endogenously in the liver is either converted to bile 
acids for use in the digestive process or esterified by ACAT to CEs which are
secreted into the bloodstream as a part of very low density lipoproteins 
(VLDL) together with endogenously formed TAGs (Table 5). The lipoprotein 
lipase hydrolyzes TAGs from VLDL and intermediate density lipoproteins
(IDL i.e. VLDL remnant), and finally LDLs are formed. The cholesterol supply 
in cells is maintained by regulating the rate of both LDL-receptor synthesis 
and cholesterol esterification by ACAT, as well as by regulating β-hydroxy-β-
methylglutaryl-CoA (HMG-CoA) reductase activity, the rate-limiting step in
the de novo synthesis of cholesterol (Voet and Voet 1995; Bruckner 2000). 
Most of the cholesterol-rich LDL-particles are removed from the circulation 
through the hepatic LDL-receptor pathway recognizing apolipoprotein B-100 
(Table 5), and a smaller part via the macrophage scavenger pathway.
Cholesterol is transported out of tissues by reverse transport mediated by 
ATP-binding cassette transporter 1 (ABCA1), HDL, lecithin-cholesterol acyl-
transferase (LCAT), CE transfer protein (CETP) and scavenger receptor B1
(SR-B1) in the liver (Attie et al., 2001). HDL clears cholesterol from the cells 
through transesterification of acyl groups from PC with the aid of LCAT. It is 
synthesized by the liver and secreted into the plasma, where HDL is the 
preferred substrate. LCAT is particularly activated by apolipoprotein-AI
(Table 5), and its best fatty acyl substrate is LA (Jonas 1987). HDL can also
deliver part of its CEs in exchange with TAGs, with the aid of CETP, to VLDL, 
IDL and LDL, which can then be taken up by the liver (Mensink et al., 2000). 
The serum concentration of LDL cholesterol (LDL-C) depends on the rate of 
synthesis and removal of LDL particles from the circulation which, in turn,
depends on the number of functioning LDL-receptors on the liver cell 
surface. In familial hypercholesterolemia, liver LDL receptors are diminished
or eliminated due to a genetic defect, while in normal subjects ingestion of a
high-cholesterol diet represses the rate of LDL-receptor production (Voet and
Voet 1995). Recent meta-analyses suggest that a decrease or an increase of 
100 mg dietary cholesterol/d is estimated to cause a corresponding change 
in the plasma cholesterol level of between 0.04-0.07 mmol/L (Howell et al.,
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1997; Weggemans et al., 2001). The higher the serum LDL-C level, the more
LDL-C will be cleared via the macrophage pathway. When too much LDL-C is
taken up, foam cells loaded with cholesterol are formed (Bruckner 2000), 
which can then initiate development of atherosclerotic plaque (Goor 1987). 
2.5. Effects of dietary fatty acids 
The amount and type of dietary fat have profound effects on plasma lipids
and lipoproteins, which may explain many of the effects that lipids have on
the risk factors associated with several major diseases in affluent societies 
(Norum 1992). The Seven Countries Study, which started in the late 1950s
and included two Finnish and eight other European populations, showed 
marked differences in SaFA and monounsaturated fatty acid (MUFA) intake. 
Further, a high intake of SaFAs was associated with high serum cholesterol
levels and high mortality of CHD (Keys 1970). However, confusion still
existed about why populations with low CHD could have very different 
sources of dietary fats. After finding a connection between a high MUFA 
intake and a low CHD in Mediterranean regions (Keys 1970), studies among 
Eskimos with even higher cholesterol levels reported that marine foods could
also be related to low CHD (Bang et al., 1971). These diets contained much 
more PUFAs (n-3) than typical western-type diets (Bang et al., 1976). 
2.5.1. Saturated fatty acids and associations with serum cholesterol levels 
SaFAs form a significant part of human tissue lipids derived either from the
diet or from endogenous synthesis in the liver. However, a higher intake of
SaFAs causes elevated plasma cholesterol levels by reducing the activity of
LDL receptors, and thus the receptor-mediated removal of cholesterol from 
circulation is diminished (Grundy 1987; Nelson 2000).
A high intake of SaFAs from animal fats such as butter, especially if it forms 
the main part of the dietary fat, not only leads to raised plasma cholesterol
levels but also to reduced PUFAs in the diet. Probably the highest known
SaFA intake and the lowest PUFA/SaFA (P/S) ratio (0.17) was recorded in
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Finland in the early 1970s (Trygg 1991), as well as a high CHD mortality
among men (Nikkari 1986). Population surveys in eastern Finland during 
1972-1992 indicated that the observed decline in IHD mortality, which was 
higher than predicted, was 55% and 68% in men and women, respectively 
(Vartiainen et al., 1994). As much as 3/4 of the decline could be explained 
by changes in common risk factors, i.e. serum cholesterol, blood pressure
and smoking, half of which was related to the decrease in serum cholesterol 
levels. During that period, substantial changes in the quality of dietary fat 
were made, i.e. a decrease in the use of butter and an increase in the use of
margarines.
The exceptionally high SaFA intake, serum cholesterol levels and CHD rate 
in Finland (Keys 1970) have usually had no point of comparison in other 
countries. Sometimes it is well documented that serum cholesterol levels in a 
given population are closely correlated with an increased risk for athero-
genesis (Bruckner 2000). In contrast, the factors influencing plasma 
cholesterol have been also considered of secondary rather than primary 
importance in CHD, and that the true mechanisms are still not clear (Gurr
1992). What still remain questions are why there is lower CHD mortality in
some countries (e.g. France) despite substantial cholesterol and fat intakes,
or why the number of CHD deaths can clearly be different at the same 
cholesterol levels (Bruckner 2000). 
2.5.2. Trans-fatty acids
High amounts of trans-fatty acids (TFAs), derived from hardening by partial
hydrogenation of vegetable oils, also belong to the adverse components of 
dietary fats. However, the use of interesterification as an alternative to 
hydrogenation (deMan 2000) has resulted in a clearly lower intake of TFAs,
especially in Europe. The average total trans-fatty acid intake in Finland is 
about 1 g/d (Laatikainen et al., 2003), while the supply of 18:1trans from 
margarines and shortenings in the Danish diet has been the same (Ovesen et 
al., 1998). In Germany, vegetable and fat-reduced margarines have 
contained 0.3-4%, and diet margarines ?0.5% of trans-isomers (Fritsche and 
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Steinhart 1997). However, 'hidden' fat can sometimes contain an abundance
of TFAs, as found in fast-food frying fats (up to 20%) (Ovesen et al., 1998).
The high intake of TFAs in North American diets is mainly derived from
bakery products, cookies, biscuits, snacks and deepfried food products,
while the proportion of margarines accounts for about 1/4. Deepfried foods 
can supply as much as 10 g/d of TFAs. However, the trans-contents do not 
have to be labeled, but the products can be advertised as cholesterol-free, 
low in SaFAs and cooked in vegetable oil (Ascherio et al., 1999). Adverse 
effects caused by a high intake of TFAs (Craig-Schmidt and Holzer 2000)
have led demands for labeling high TFA levels in food products (Ascherio et 
al., 1999). 
A major concern is especially focused on the safety aspects of a high intake 
of TFAs in pregnant and lactating women and in newborn infants. There are 
indications that TFAs correlate inversely with birth weight, and that they can
impair EFA metabolism and early growth (Koletzko 1992). The most adverse
effect is that a high intake is easily reflected in breast milk, and that high
TFA levels even occur in other baby foods (Holub 1999). 
Studies on the effects of TFAs on serum lipid levels have shown that a total
energy intake covering 11% of TFAs not only raises LDL-cholesterol but also
lowers HDL-cholesterol levels (Mensink and Katan 1990). These effects have
been also reported at lower energy levels of TFAs (3-8%) (Ascherio and Willett 
1995).
In the 1990s, several epidemiological studies on U.S. populations indicated 
that a high intake of TFAs can contribute to a risk of myocardial infarction
(MI) (Ascherio et al., 1994) and CHD (Willett et al., 1993; Ascherio et al., 
1996; Hu et al., 1997). In contrast, in a study including eight European
countries no associations were found between adipose tissue TFA levels and 
the risk of MI (Aro et al., 1995). Serum lipid levels were not determined but, 
instead, cigarette smoking was found to be the only significant risk factor for
sudden cardiac death in this population. 
31
2.5.3. Monounsaturated fatty acids
Among edible oils, the effects of MUFAs can be best monitored on the basis
of the most typical monoenoic oil: olive oil which is composed of about 75%
OA and 8% LA. A low incidence of CHD found among Mediterranean
populations (in Corfu and Crete) already in the 1960s was considered to be 
related to the use of olive oil as the principal dietary fat (Keys 1970; Grundy 
1987; Kris-Etherton 1999). A number of studies based on olive oil diets have 
focused on serum lipid levels. Comparisons can be best made when diets 
simulate both the MUFA and especially the PUFA contents of the oil.
The effects of an olive oil-rich diet (64% MUFAs, 9% PUFAs) were compared
with those of a corn oil diet (36% MUFAs, 36% PUFAs) in two groups of
subjects having serum TC levels of 6.2 and 7.2 mmol/L, respectively. The
olive oil diet had no TC-lowering effect, while the corn oil diet reduced it by 
8% (p<0.01) and 7% (p<0.05), respectively. After a corn oil diet, olive oil had 
an HDL-C raising effect (5%; p<0.05) (Sirtori et al., 1986). An olive oil-rich 
diet with a similar MUFA/PUFA ratio was consumed by subjects with TC
levels of 5.9 mmol/L (Baggio et al., 1988). Dietary compliance was assessed
by erythrocyte membrane fatty acid analysis, which showed a rise of 15% in 
OA without changes in PUFA levels. The fall in TC, LDL-C and TAGs were 9,
12 and 25%, respectively, but without any effect on HDL-C levels.
In a recent study on young men with clearly lower TC levels (4.7 mmol/L), 
the plasma TAGs, TC and VLDL, IDL and LDL cholesterol concentrations
remained higher after an olive oil-rich diet (60% MUFAs and 9% PUFAs) 
compared to rapeseed oil and sunflower oil diets. The different squalene and 
phytosterol contents of the oils were assumed to be partly responsible for the
differences in plasma lipid levels (Pedersen et al., 2000). 
The effects of diets with about 60% of MUFAs but higher amounts of PUFAs 
(13%) have been studied in subjects with TC levels of 5 mmol/L. The use of
MUFAs derived from both olive oil and rapeseed-oil based margarine resulted 
in a decrease in TC and an increase in HDL-C concentrations (Mensink and
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Katan 1987). In a study performed on 63 healthy male subjects aged 
between 18-75 years, an olive oil diet had no effect on TC but raised both
HDL-C and TAG levels (Jacotot et al., 1988). 
Comparisons have been also made when MUFA diets contain PUFAs
equivalent to 20% of total fat even (Mensink and Katan 1989). As dietary
enrichment with olive oil increases LA in plasma CE by 4 %-units (n.s.) but 
not OA, the effect cannot be due to MUFAs. Instead, such a rise in CE can be 
obtained from a moderate LA content in rapeseed oil diet, for example (Valsta
et al., 1995). In plasma PLs and CEs, olive oil brings about an increase in OA 
and a decrease in LA (Seppänen-Laakso et al., 1993a; Nydahl et al., 1994).
The effects of MUFAs, i.e. OA, are beneficial when replacing SaFAs (Grundy 
et al., 1988). After a SaFA diet or in subjects with hyperlipidemia, rapeseed
oil-based diets have reduced serum cholesterol levels by 15-20% (McDonald
et al., 1989; Valsta et al., 1992; Nydahl et al., 1994; Gustafsson et al., 1994). 
MUFA-rich oils such as olive, canola-type rapeseed or high oleic sunflower
oils may not have similar plasma cholesterol-lowering effects (Truswell and 
Choudhury 1998), but they favourably affect on CHD risk factors related to 
thrombogenesis, in vitro susceptibility of LDL to oxidation compared with 
PUFAs, and insulin sensitivity (Kris-Etherton 1999).
2.5.4. N-6 and n-3 polyunsaturated fatty acids and eicosanoids 
Since the discovery of the essentiality of linoleic and linolenic acids in 1930,
more detailed research on their effects in humans remained in the back-
ground for decades simply because fatty acids were difficult to measure 
before the appearance of GC techniques. In contrast, cholesterol, a non-
essential, abundant compound also synthesizable by the body, could be 
easily measured by colorimetry (Holman 1992). Much later on, the use of
edible oils rich in LA increased to replace SaFAs and to lower cholesterol
levels, as in the U.S. diet in the 1970s. Not until recently, however, has
α-LLA been accepted as a significant member of the n-3 PUFA family
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together with marine n-3 PUFAs (Holman 1998; Simopoulos 1999; Chapkin 
2000).
N-6 PUFAs. LA-poor diets, in contrast, have indicated a marked imbalance in 
the PUFA/SaFA intake, and low LA levels in serum and adipose tissue lipids 
were frequently found in CHD patients (Nikkari 1986). Several studies on
populations with different CHD mortality also concluded that lower LA levels 
rather than classical risk factors would explain the higher CHD rates (Logan 
et al., 1978; Wood et al., 1984, 1987; Riemersma et al., 1986). A five-year
follow-up study on Finnish men showed that low PUFA contents in serum
PLs is predictive for IHD (Miettinen et al., 1982). The subjects who had
sustained fatal or non-fatal myocardial infarction not only had lower LA and 
longer-chain n-6 PUFA, but also lower n-3 PUFA levels. 
It has become clear that LA, earlier considered to be the entire dietary PUFA, 
not only has cholesterol-lowering properties but also a regulatory role via n-6
PUFA and eicosanoid metabolism (Lands et al., 1992; Holman 1998; Hwang 
2000). However, the different dietary PUFA composition in populations with
a low CHD are difficult to put into the same category. In traditional 
Mediterranean diets, olive oil was low in LA and practically free of α-LLA,
while marine food diets in Japan (Keys 1970) and among Eskimos (Dyerberg 
1986) were rich in n-3 PUFAs.
Increased use of LA-rich (>50%) vegetable oils in some western diets, which 
means placing too much emphasis on n-6 PUFAs at the expense of n-3 
PUFAs and thereby affecting eicosanoid balance, has been a matter of
increasing concern (Budowski et al., 1984; Lands et al., 1992; Holman 1998;
Lands 2000; Chapkin 2000). The eicosanoids possess diverse actions on the
cardiovascular, reproductive, respiratory, renal, endocrine, skin, nervous 
and immune systems. An imbalance in eicosanoid synthesis is found in 
pathological conditions like thrombosis, inflammation, asthma, ulcers and
kidney disease (Hwang 2000). LA (n-6) is metabolized to HGLA and AA. 
HGLA forms prostaglandin PGE1 which inhibits platelet aggregation, while 
thromboxane TxA2 and leukotriene LTB4 derived from AA are potent
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aggregatory and inflammatory agents, respectively (Crawford 1983; Drevon 
1992; Hwang 2000). The metabolism of α-LLA (n-3) to EPA or more efficient
direct intake of EPA leads to antiaggregatory prostacyclin PGI3. Leukotriene 
LTB5, in turn, is less aggregatory than its competitive analog LTB4 (Dyerberg
et al., 1978; Crawford 1983; Cleland 1992). 
N-3 PUFAs. The low mortality rate of IHD among Eskimos has provided 
significant evidence of the benefits of n-3 PUFAs in the diet (Dyerberg et al., 
1975; Dyerberg 1986; Leaf and Kang 1998). The traditional Eskimo diet was
rich in protein and fat but poor in carbohydrates, and consisted mostly of
the meat of whales, seals, sea birds and fish. Potatoes and other vegetables,
and dairy products were eaten in very small amounts. In their plasma,
typical features included low TAG levels. These findings were supposed to 
explain the low CHD and the absence of diabetes in the population (Bang et 
al., 1971). In particular, high EPA and low AA levels were suggested to be 
responsible for the antithrombotic state via the functions of prostacyclin 
involved in the platelet-vessel wall interaction (Dyerberg et al., 1978). 
The majority of the studies on fish oils have shown an effective decrease in
serum TAG levels (25-30%), and an increasing trend for LDL-C (5-10%) and
for HDL-C (1-3%) (Harris 1997). Consistent effects of long chain n-3 PUFAs 
also include the inhibition of platelet aggregation, prolonged bleeding time 
(Siess et al., 1980; Goodnight et al, 1981; Lorenz et al., 1983; Ahmed and
Holub 1984), and a reduction in AA-derived thromboxane TxA2 formation
(Siess et al., 1980; Lorenz et al., 1983; von Schacky et al., 1985). Desirable
effects of n-3 PUFAs have been often reported, and diets containing fish have 
become an important means to maintain n-3 PUFA intake. 
Moderate consumption of fish already as little as once or twice a week in the
western-type diet has been shown to be inversely associated with twenty-
year mortality from CHD (Kromhout et al., 1985). Evidence on cardio-
protective effects has been obtained in animal studies, which showed that all 
major dietary n-3 PUFAs (α-LLA, EPA and DHA) significantly prevented fatal
arrhythmias (Leaf and Kang 1998). Although LA and AA were also anti-
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arrhythmic several cyclo-oxygenase metabolites derived from AA appeared to
induce violent arrhythmias (Kang and Leaf 2000). 
Dietary intake is the only route of entry for eicosanoid precursors. These 
long-chain n-6 and n-3 PUFAs are obtained from the metabolism of LA and 
α-LLA and also by direct intake. Thus, the n-6/n-3 PUFA balance can be
affected much by food choices (Lands 2003). New evidence of the significant
role of the n-6 PUFAs (HGLA and AA) is shown in Fig. 2, where the highest 
tissue proportions of long-chain n-6 PUFAs (i.e. the lowest n-3 PUFAs; EPA,
DHA) out of total long-chain PUFAs are closely related with the highest CHD.
Fig. 2. The association between CHD mortality and the proportion of tissue
long-chain n-6 PUFAs (HUFAs) from total long-chain PUFAs (HUFAs). 
(Printed with permission of AOCS from Lands 2003). 
When seven populations are compared, the proportions of tissue n-6 PUFAs 
vary by as much as 30 to 80%. The results from the three latest studies on 
Canadian populations (Québecers, James Bay Cree and Inuit of Nunavik)
with a 10-fold difference in the daily intake of fish (Dewailly et al., 2003),
fitted closely to the relationship between populations with the lowest 
(Greenlanders and Japanese) and the highest CHD (U.S.) (Lands 2003). 
An increase in long-chain n-3 PUFAs in tissues via metabolism of α-LLA
cannot be, of course, compared with that derived from direct intake of EPA
and DHA-containing fats (Li et al., 1999). However, a high intake of long-
chain n-3 PUFAs was not predominant in the Mediterranean populations
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having a low CHD. Their traditional diets contained abundantly plant foods
(fruits, especially leafy vegetables like lettuce, spinach and purslane, breads, 
other forms of cereals, potatoes, legumes, nuts and seeds), olive oil as the 
principal source of fat, and dairy products (mainly cheese and yogurt), fish 
and poultry in low to moderate amounts (Keys 1995; Willett et al., 1995). 
Relatively high tissue contents of α-LLA were found in Cretan men especially,
indicating that sources like green leafy vegetables can even supply α-LLA in 
sufficient amounts for effective n-3 PUFA metabolism, especially when it is
not interferred by high intakes of SaFAs and LA (Simopoulos 1998).
Early evidence on the antithrombotic effects of α-LLA-containing diets has
been obtained from long-term studies in farmers, where an increase in EPA 
and a decrease in AA level both in plasma lipids and platelet PLs led to a 
reduced platelet aggregation and prolonged clotting time of PRP. Beneficial 
functions were attributed to a higher intake of α-LLA from rapeseed oil 
(Renaud and Nordøy 1983; Renaud et al., 1986), which has also often been 
found in more recent studies (McDonald et al., 1989; Kwon et al., 1991). 
Linseed (flaxseed) oil is another marked source of α-LLA, which also has 
desirable platelet functions (Budowski et al., 1984; Mantzioris et al., 2000). 
Long-chain n-3 PUFAs derived from α-LLA are especially enriched in plasma 
PL subclasses. An increase in EPA after a one-week rapeseed (canola) oil 
intake was already seen in the alkenylacyl ethanolamine fraction and choline 
phosphoglycerides of platelet PLs, showing concomitant reduction in long-
chain n-6 PUFAs (Weaver et al., 1990; Chan et al., 1993). After replacing
highly saturated fat, rapeseed oil increased both EPA and LA in the sn-2
position plasma PC fraction (Seppänen-Laakso et al., 1993b). An increase in 
long-chain n-3 PUFAs was similarly detected in the serum PL of the subjects 
with even higher cholesterol levels (Gustaffsson et al., 1994). The most 
consistent n-3 PUFA effect of linseed oil, containing about 16% LA and 53%
α-LLA, is a rise in plasma PL EPA (Budowski et al., 1984; Dyerberg 1986;
Cunnane et al., 1993; Mantzioris et al., 1994; Li et al., 1999). An enrichment 
of n-3 PUFAs has been also seen in PL subfractions during linseed oil 
supplementation (Sanders and Younger 1981; Chan et al., 1993).
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An increasing number of studies on populations with western-type diets 
suggest an inverse association between α-LLA intake and CHD (Ascherio et 
al., 1996; Hu et al., 1999; Djoussé et al., 2001). When using plasma PL fatty
acids as indicators, higher combined EPA and DHA levels were related to a 
lower risk of fatal IHD, while only a similar tendency was found for α-LLA
(Lemaitre et al., 2003). In a 5-year study, higher EPA contents in CEs
derived from fish intake were associated with a lower risk of CAD death, 
whereas higher α-LLA, EPA and DHA levels were related to a lower risk of all-
cause mortality (Erkkilä et al., 2003). In a secondary prevention trial, a
Mediterranean diet enriched with α-LLA resulted in a marked reduction in
CHD mortality (de Lorgeril et al., 1994).
2.5.5. Associations between polyunsaturated fatty acids and lipid oxidation 
The few adverse effects of PUFAs include enhancement of the susceptibility
to oxidation of LDLs. A number of oxidation products formed especially from 
LA and AA have been detected in the oxidized LDL fraction (Esterbauer et al.,
1987, 1997; Aviram and Vaya 2001). These n-6 PUFAs are abundant in LDL, 
while n-3 PUFAs occur in minor amounts only (Esterbauer et al., 1987). An
increase in LDL oxidation has been observed, in particular after a high
intake of LA (Reaven et al., 1991; Louheranta 1996).
The adverse effects of n-3 PUFAs after fish oil intake are thought to arise 
from high doses or too long supplementation, wheras low (<1 g) doses do not
influence LDL oxidation (Higgins et al., 2001). A moderate supply (2.5 g/d) of
n-3 PUFAs increases EPA and DHA in LDL and decreases n-6 PUFAs without 
enhancing the susceptibility to oxidation. By using n-3 PUFAs originally not 
abundant in LDL, it is thus possible to suppress the dominant effect of n-6
PUFAs in the LDL fraction (Bonanome et al., 1996). Studies on rapeseed oil 
containing moderate amounts of LA and α-LLA have also indicated no 
marked effects on lipid peroxidation (Corboy et al., 1993; Turpeinen et al., 
1995; Södergren et al., 2001). The relatively high tocopherol content of the 
oil, which was reflected as an increase in the serum gamma-tocopherol level, 
was assumed to act as a potent antioxidant (Södergren et al., 2001).
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3. AIMS OF THE STUDY 
The main interest in the research on the health effects of dietary fats is 
focused on their response in the serum lipids and plasma fatty acid 
composition. In the present investigations, a gas chromatographic (GC) 
technique using a novel programmed temperature vaporizing (PTV) injection 
in fatty acid analysis and high-performance liquid chromatography (HPLC) in
the determination of plasma lipid classes were applied. The effects of
vegetable oils on serum lipids and the plasma fatty acid composition were 
studied in free-living, mildly hypercholesterolemic subjects during partial fat 
substitutions. The changes in PUFA levels in plasma PL derived from dietary 
EFAs were particularly examined. The specific aims of the studies were: 
1. To optimize GC and other methods for total plasma and plasma PL fatty
acid analyses including octadecenoic trans-fatty acid isomers, and to 
study their variation in subjects having habitual diets (I, IV). 
2. To study the effects of rapeseed oil and margarine substitutions on
serum lipid levels, and the plasma total and PL fatty acid composition, 
and their associations when replacing butter on bread (II, IV). 
3. To study the effects of rapeseed oil and olive oil substitutions on serum
lipid levels, and the plasma total and PL fatty acid composition, and their 
associations when replacing margarine on bread (III, IV). 
4. To optimize an HPLC method using evaporative light-scattering (ELS)
detection in quantitative analysis of plasma lipid classes, and to study 
their associations with serum lipid levels and the plasma PL fatty acid 
composition. In addition, the effects of ordinary and cold-pressed 
rapeseed oil and soybean oil substitutions were examined (V). 
5. To review the methodology in food and human tissue fatty acid analysis, 
and to describe the responses in plasma during fat substitutions (VI). 
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4. EXPERIMENTAL 
4.1. Subjects and substitutions 
4.1.1. Selection and grouping of the subjects
Study 1 (I-IV). In a screening study, completed in the Turku area in January 
1988, a total of 400 middle-aged men and women participated. The subjects
answered a questionnaire about the consumption of fat, bread, fat on bread,
milk products, eggs, fat-containing supplements and medical drugs. A 
number of subjects were excluded due to minor use of bread and fat on 
bread (<3 slices of bread/day, n = 38), drug therapy (n = 37), or the use of
fat-containing supplements, such as cod-liver oil (n = 31). 
The subjects with TC levels between 5.0 and 8.5 mmol/L, TAG less than 3.5
mmol/L and body mass index (BMI; kg/m2) not more than 25, were accepted 
for the final study (n = 100). Subjects using butter on bread were divided 
alphabetically into rapeseed oil (n = 20; II) and margarine (n = 23; II, IV)
groups, and subjects using common margarines (III, Table 2) (Table 7) into 
rapeseed oil  (n = 23; III) and olive oil (n = 23; III, IV) groups. The control 
group (n = 11; II-IV) consisted of mixed fat users.
Table 6. The fat on bread before and during substitution, age, BMI, and 
serum TC and TAG levels of the study groups. Values are 
expressed as means (SEM). 
__________________________________________________________________________________________
Butter users Margarine users Mixed fat users
 __________________________ _________________________ ________________
Characteristics Rapeseed Test margarine Rapeseed Olive oil Control
of the groups oil, n=20 n=23 oil, n=23 n=23 n=11
__________________________________________________________________________________________
Age (years) 45.7 (2.0) 44.8 (1.7) 45.5 (2.0) 44.6 (1.8) 41.7 (1.9)
Men / Women 10/10 11/12 12/11 13/10 5/6
BMI (kg/m2) 25.7 (0.7) 25.4 (0.9) 26.9 (0.8) 24.7 (0.6) 24.6 (0.7)
TC (mmol/L) 6.32 (0.18) 6.15 (0.13) 6.07 (0.14) 6.28 (0.21) 6.06 (0.19)
TAG (mmol/L) 0.99 (0.09) 0.92 (0.09) 1.34 (0.12) 1.00 (0.13) 0.85 (0.10)
__________________________________________________________________________________________
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Study 2 (V). The subjects (n = 48) for another study (1996) were selected from 
the registry of the Helsinki University Hospital of Skin and Allergic Diseases 
and by an advertisement in a newspaper. The participants visited a medical
doctor and filled in a diet questionnaire. The study was accepted by the
Ethics Committee of the hospital. The subjects, who were mainly margarine 
users, and the majority used no fish in their habitual diets, formed cold-
pressed rapeseed oil (n = 26), ordinary rapeseed oil (n = 16) and soybean oil 
(n = 6) groups. 
4.1.2. Substitutions and substitute fats 
Study 1 (I-IV). The substitution period lasted for 6 weeks, during which 
butter on bread was replaced by rapeseed oil or substitute test margarine 
prepared for the study (II). Similarly, margarine on bread was replaced by
rapeseed oil or olive oil (III). No other changes were made in the diet. The
subjects returned to using butter or margarine on bread during the post-
experimental period (the following 6 weeks). The control group was asked to 
maintain its normal diet during the 12-week trial.
Rapeseed oil or olive oil was used on bread as a water-oil emulsion (fat
content 65%). The test margarine contained rapeseed oil (24%), sunflower, 
coconut and partially hydrogenated soybean oils (fat content 80%). The fatty 
acid compositions, including 18:1trans-fatty acids, are shown in Table 7, as 
well as those of margarines and butter used before the substitutions. 
In addition, the proportions of OA, LA and α-LLA in the sn-2 position of 
rapeseed oil TAGs were determined, and they accounted for 50.2, 33.0 and
16.5%, respectively. The corresponding values for olive oil were 85.8, 12.3 
and 1.1% (Seppänen-Laakso et al., 1995a).
Study 2 (V). Rapeseed oils and soybean oil (Table 7) were given for 6 weeks in
parallel design. They were used as a part of the habitual home-diets as salad 
dressings, for instance. Margarine, cheese or butter on bread were designed 
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to be replaced by a corresponding dose of cold-pressed or ordinary rapeseed 
oil or soybean oil.
Table 7. Fatty acid composition of the fats before and during substitutions. 
__________________________________________________________________________________________
Fat on bread Substitute fat 
 before __________________________________________________
 substitution Study 1 Study 2
Fatty acids ____________________ ________________________ _________________________
 (%) Butter Margarines1 Rape- Olive Test Cold- Rape- Soy-
seed oil margarine pressed seed bean
oil rapeseed oil oil
oil
__________________________________________________________________________________________
Total SaFAs 69.7 24.1 5.7 13.9 20.6 4.6 5.6 14.8
10:0-14:0 19.7 4.8 0.1 0.1 4.5 0.1 0.1 0.1
 16:0 Palmitic 36.0 10.8 3.3 10.6 8.0 2.6 3.3 10.2
18:0 Stearic 13.8 7.8 1.5 2.7 7.2 1.3 1.5 3.8
20:0-24:0 0.2 0.7 0.8 0.5 0.9 0.6 0.7 0.7
Total MUFAs 28.1 40.1 59.8 75.7 48.5 62.2 59.8 23.1
16:1 Palmitoleic 1.6 0.2 0.1 0.5 0.1 0.1 0.2 0.1
 18:1 cis Oleic 24.3 31.1 57.2 74.6 31.1 61.1 57.2 22.7
 18:1 trans 1.9 8.1 - - 16.4 - - -
20:1 Eicosenoic 0.3 0.5 1.6 0.5 0.6 0.9 1.5 0.2
22:1 Erucic - 0.2 0.9 0.1 0.3 0.1 0.9 0.1
n-6 PUFAs2 1.7 33.6 24.4 9.2 28.2 21.2 23.6 54.9
18:2 Linoleic acid 1.7 33.5 24.3 9.1 28.1 21.1 23.5 54.8
n-3 PUFAs
 18:3 α-LLA 0.5 2.2 10.1 1.2 2.7 12.0 11.3 7.2
__________________________________________________________________________________________
1 Mean of 5 common margarines; 2 incl. 0.1% 20:2 in vegetable fats.
4.1.3. Dietary control 
Study 1 (II-IV). All the subjects kept 3-day dietary diaries before and towards 
the end of the substitution period, and the data obtained were analysed for 
nutrients using a food table-based Nutrica® programme. In addition, the
consumption of oil emulsions and margarine was controlled twice (at 3 and 6 
weeks). Body weight was recorded at blood sample drawings, i.e. before 
substitution and at 3, 6 and 12 weeks. 
Study 2 (V). The 6 weeks’ use of substitute oils was controlled by 3-day 
dietary diaries, and the consumption was also recorded when the subjects 
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returned the unused oil at the end of the study. The 3-day dietary diaries 
were made before and during substitution (at 3 weeks). The data were 
analysed by Nutrica® programme. Compliance to the substitutions was also 
followed by total plasma (II, III) and plasma PL fatty acid analyses (II-V). 
4.1.4. Blood sampling 
Fasted blood samples were taken two weeks before the substitutions. During 
Study 1 (I-IV), fasted blood samples were taken at the baseline, after 3 and 6 
weeks’ substitution, and at the end of the post-experimental period (at 12 
weeks) at Vagus Medical Laboratory, Turku, Finland. Platelet-rich (PRP) and
platelet-poor EDTA plasma (PPP) samples were prepared by centrifugation at 
180 G (8 min) and 2000 G (20 min), respectively, and stored at -20°C.
In Study 2 (V), fasted blood samples were taken before the substitutions (at 
the baseline), at 3 weeks (data not shown) and at the end of the study (6 
weeks), in the Laboratory of Helsinki University Central Hospital.
4.2. Analytical methods 
4.2.1. GC analyses of plasma fatty acids (I-V) 
Lipid extraction. For GC analysis, all the plasma samples (0.5 ml) were
extracted with chloroform/methanol (2:1) by a partially modified Folch et al. 
(1957) method. For quantitative analysis (I), internal standards for bound 
and free fatty acids (FFA), respectively, were added. The lower phase was
separated and evaporated to dryness and dissolved in petroleum ether. 
Isolation of phospholipids. For the analysis of PL fatty acids, the residues of 
the lipid extracts were re-dissolved in chloroform and applied on Silica gel 
60F254 glass plates. The plates were developed with petroleum ether/diethyl 
ether/acetic acid 85:15:2 (Nelson 1967). The PL fractions were scraped off, 
extracted with chloroform/methanol, evaporated and dissolved in petroleum
ether for esterification (I).
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Transesterification. Derivatization was optimized for bound plasma fatty
acids by modifying earlier methods (Appelqvist 1968; Hiltunen et al., 1979).
Sodium methoxide (NaOMe) in dry methanol was added to the lipid extracts 
in petroleum ether, and methylated at 40°C for 5 min (Seppänen-Laakso et 
al., 1989b). No decomposition of FAMEs during methylation was found (I), 
and the method was used throughout the studies. In II-V, total fatty acids 
refer to bound fatty acids. After neutralization, petroleum ether was added 
and a 1 µl aliquot was used for GC analysis.
Gas chromatographic conditions. The analyses were carried out on a DANI 
3865 GC using a PTV sampling technique with split mode (I). The GC was 
equipped with an NB-351 fused silica column (25 m, 0.32 mm I.D., film 
thickness 0.20 µm; Nordion, Helsinki, Finland). The oven was programmed 
from 100°C to 235°C at 10°C/min under the following conditions: carrier gas 
H2 (2.5 ml/min), split ratio 50:1, flame ionization detector (FID) 250°C, PTV-
injector 70°C → 250°C (rate ~50°C/s). The effect of the split ratio on the
relative amounts of FAMEs was controlled with a reference mixture. 
Identification of fatty acids (I,IV). Identification of FAMEs and major FFAs was 
based on the retention times of reference standards and on those presented 
in the literature (Slover and Lanza 1979; Bohov et al., 1984; Krup?ik and
Bohov 1985). The methodological variation including the steps described
above were determined by repeated GC analyses. 
Isolation of the 18:1trans isomers (IV). The double-bond distributions of 18:1 
trans-fatty acids were determined by AgNO3-TLC and ozonolysis. FAMEs
from the test margarine, butter and pooled plasma PL samples were applied 
on AgNO3-impregnated Kieselgel 60 plates (Merck, Darmstadt, Germany). 
After development with chloroform containing 0.75% ethanol and spraying 
with 2',7'-dichlorofluorescein (0.2% in ethanol), the 18:1trans-bands were 
scraped off and extracted with hexane/chloroform (1:1, v/v) (Ratnayake and 
Beare-Rogers 1990). 
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Identification of ozonolysis products by GC-MS (IV). The isolated bands were
ozonised by bubbling the samples for 2 min in 1.2% ozone (4.8 mg/sample)
developed by an ozonizator. The products were then methylated with
diazomethane and analysed by GC-MS (HP 5890 GC) equipped with an NB-
54 fused-silica capillary column (15 m, 0.20 mm I.D., film thickness 0.25
µm; Nordion, Helsinki, Finland) and interfaced with an HP 5970A MS 
detector operating at EI mode (70 eV). Pure elaidic acid (18:1n-9trans) was 
ozonized to confirm the elution order and spectra of the four major products: 
nonanal, nonanoic acid, nonanoic acid aldehyde and nonanoic diacid. 
Analysis of plasma PL 18:1trans fatty acids (IV). Routine analyses were 
performed on an SP-2340 fused-silica capillary column (60 m; 0.25 mm I.D., 
film thickness 0.20 µm; Supelco, Gland, Switzerland). A DANI 3865 GC
equipped with a PTV injector was used in solvent split sampling mode (split 
ratio 50:1) (Poy et al., 1981). After manual injection (PTV at 70°C) the split
valve was open for 6 s, then closed (and PTV heated to 235°C) and opened
again after 60 s. A two-step oven temperature programme from 70°C (at 
7°C/min) to 150°C and then to 180°C (at 1°C/min) was used. Carrier gas 
(H2) flow was 0.6 ml/min and the detector (FID) temperature 235°C.
Stereospecific analyses. Pancreatic lipase was used to hydrolyse sn-1 and
sn-3 fatty acids from TAGs in vegetable oils (Seppänen-Laakso et al., 1995a). 
The incubation (37°C, 15 min) products were extracted with diethylether. 
Monoacylglycerols containing fatty acids in the sn-2 position were isolated by 
TLC (Myher and Kuksis 1979), transesterified and analysed by GC.
Plasma PC fractions from 20 subjects (II) were isolated by TLC (Kovács et al., 
1988), and fatty acids from sn-2 position were cleaved with phospholipase A2
(20°C, 24 h). After hydrolysis, transesterification produces FAMEs from sn-1,
whereas FFAs originate from sn-2. Major FAMEs and FFAs were analysed by 
GC (Seppänen-Laakso et al., 1993b). Minor long-chain sn-2 PUFAs (C20-
C22, as FFAs) were trimethylsilylated and analysed by GC-MS-SIM according 
to the method as described earlier (Seppänen-Laakso et al., 1990b). 
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4.2.2. HPLC analyses of plasma lipid classes (Study 2; V) 
For quantitative determination of plasma lipid classes by HPLC, 200 µl
aliquots of plasma were extracted by chloroform/methanol and centrifuged. 
The lower layer was separated and filtrated, and 7 µl aliquots were used for 
injection.
Plasma CE, FC, TAG and PC concentrations were determined by HPLC using
ELS detection (Cunow DDL21, Cergy St. Christophe, France). Separation of 
the lipid classes was carried out on a SpherisorbTM S3W column (100 × 4.6 
mm I.D., particle size 3 µm; Phase Separations Ltd., UK) using a gradient 
elution based on solvent mixtures described by Christie (1986). The flow rate 
was 2 ml/min, detector temperature 40°C and air flow 27 psi. The method 
was validated by determining the average repeatabilities of the injections,
intra- and inter-day variations and extraction recoveries for each plasma 
lipid class.
4.2.3. Serum cholesterol and triacylglycerol measurements 
Study 1 (I-IV). Serum lipid concentrations were determined at Vagus Medical 
Laboratory, Turku, Finland. TC and TAG levels were analysed enzymatically
using CHOD-PAP (Boehringer) and Mercotest (Merck) kits, respectively. HDL-
C was determined enzymatically after precipitation of VLDL-C and LDL-C
with polyethylene glycol 6000 (Viikari 1976). LDL-C levels were calculated
using Friedewald's formula: LDL-C = TC - HDL-C - TAG/2.2 (Friedewald et 
al., 1972). 
Study 2 (V). Plasma TC and TAG levels were determined enzymatically in the 
Laboratory of Helsinki University Hospital. HDL-C was measured with the 
same technique after precipitation of LDL-C and VLDL-C with dextran 
sulphate-magnesium chloride reagent (Finley et al., 1978). Serum LDL-C 
was calculated according to the Friedewald's formula. 
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4.3. Statistical methods 
The two-week variabilities for total plasma and PL fatty acids were calculated 
by the following formula: [| X2Weeks – X0Weeks |/(X0Weeks + X2Weeks)/2] × 100%, 
where X2Weeks is the sample taken 2 weeks before fat substitution, and
X0Weeks is the sample taken at the baseline (just before substitution).
Statistical differences in lipid and nutrient levels were analysed by the paired 
or unpaired t-test (within groups and between groups, respectively). 
Pearson's correlation coefficients and regression analysis were used in
studying the relationships between plasma PL fatty acid compositions and 
serum cholesterol concentrations and plasma lipid classes. All the
significance levels (p?0.05%) are given two-sided. 
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5. RESULTS 
5.1. Reproducibility of the analytical methods 
GC analysis of total plasma (PPP) fatty acids. The determinations included all 
the study subjects who were habitual butter (n = 43), margarine (n = 46) or
mixed fat users (n = 11). The mean reproducibility of the method including 
lipid extraction, derivatization and GC run was 4.5% (RSD) for quantitative
(I, Table 1) and 2.4% for relative amounts of 14 FAMEs in total plasma. The 
total amount of the bound fatty acids in PPP correlated significantly
(r = 0.87, p<0.001, n = 100) with the serum TAG values determined enzy-
matically (I, Fig. 2a). 
GC analysis of phospholipid (PL) fatty acids. The average reproducibility of 
the method consisting additionally of TLC isolation of PLs, was 3.9% (RSD) 
for 12 FAMEs. The proportion of the methodogical variation out of the total 
variation of the population, based on variances, was the highest for palmitic 
(16:0) and stearic (18:0) acids and DPA (22:5n-3) and DHA (22:6n-3) (I, Table
3). The repeatability for the two main PL trans-isomers, elaidic (18:1n-9trans)
and vaccenic acids (18:1n-7trans), analysed directly by GC i.e. without 
preceding TLC isolation, was 3.4 and 2.7% (RSD), respectively (IV, Table 4).
Stereospecific analyses. The reproducibility of the determination of major 
sn-2 fatty acids from vegetable oil TAGs was 3.9% (RSD), on the average 
(Seppänen-Laakso et al., 1995a). In the analysis of nine sn-2 fatty acids from 
plasma PC, the repeatability of the method, including additionally TLC
isolation of PC and phospholipase A2 treatment, was 8.7% (RSD).
HPLC-ELSD analysis of plasma lipid classes (V). The average intra- and inter-
day precisions of the assay, including high and low lipid concentrations, 
ranged between 1.9 - 4.5% (RSD) and 2.3 - 7.2%, respectively, for CE, FC, 
TAG and PC in pooled plasma. The relative recoveries of the lipids varied 
between 97-110%.
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5.2. Variation of plasma fatty acids and serum lipids 
5.2.1. Two-week variability of plasma fatty acids before fat substitutions 
The variability of total plasma fatty acids within the two-week period ranged
from ±2.4 to ±13.9% (n = 89); the lowest variabilities were found for SaFAs 
(16:0; 18:0). The corresponding levels for α-LLA and OA were ±10.1 and 
±4.4%, respectively (Seppänen-Laakso et al., 1995b). The mean increase in 
α-LLA during rapeseed oil substitutions (II+III, n = 43) was 29% and that in 
OA during olive oil substitution (III) 13% higher than at the baseline. These
fatty acids were most indicative of the use of these oils. 
The two-week variability of palmitic (16:0) and stearic acid (18:0) and LA in
plasma PL ranged between ±3.0 to ±4.1% (Seppänen-Laakso et al., 1995b) 
(Fig. 3). The proportions of methodological variations for 16:0 and 18:0 
(indicated by black bars in the figure) were 29 and 21%, respectively. 
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Fig. 3. Two-week variability of plasma PL fatty acids vs methodological vari-
ation.
The most fluctuating fatty acids in plasma PLs were n-3 PUFAs, especially 
eicosapentaenoic acid (±15%; EPA) (Fig. 3). After three weeks' rapeseed oil 
substitutions (II, III), the mean increase in PL EPA was 27% higher than at 
the baseline. The decrease in SaFAs (16:0 and 18:0) most clearly exceeded
the two-week variability during replacement of butter, which was 6.3% lower 
than before  substitution (II). 
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5.2.2. Variation of fatty acids and serum lipids at the baseline 
The data in Study 1 (Table 8) show that lipid concentrations were rather 
similar between the two groups, whereas a higher SaFA and lower LA and 
total n-6 PUFA level (p<0.001) in plasma PLs is typical for butter users. 
Thus, the higher P/S ratio (0.47; p<0.001) in the diet of margarine users is
clearly reflected at plasma PL fatty acid levels. 
Table 8. Summarized data of plasma PL fatty acids and serum lipids. 
________________________________________________________________________________________
Butter users Margarine users Margarine users
Plasma PL Study 1 (n=43, II) Study 1 (n=46, III) Study 2 (n=48, V) 
fatty acids ___________________ ____________________ ____________________
(%) Mean RSD, % Mean RSD, % Mean RSD, % 
________________________________________________________________________________________
Total SaFAs 45.9 1 3.9 44.6 2.3 44.3 3.7
Total MUFAs 14.8 10.0 13.9 9.8 14.4 13.7
Total n-6 PUFAs 31.6 1 7.2 33.4 5.9 35.1 2 6.9
 18:2n-6, LA 21.2 1 10.7 22.8 9.9 22.7 13.4
20:3n-6, HGLA 2.8 21.8 2.9 21.1 3.2 21.8
 20:4n-6, AA 7.6 18.2 7.6 14.3 9.2 2 17.2
Total n-3 PUFAs 7.8 20.3 8.1 19.3 6.2 2 22.9
 18:3n-3, α-LLA 0.5 25.9 0.4 23.3 0.4 37.3
20:5n-3, EPA 1.5 36.0 1.4 40.2 1.3 37.0
22:5n-3, DPA 1.1 14.5 1.1 14.1 1.0 23.1
 22:6n-3, DHA 4.7 23.4 5.2 20.1 3.5 2 30.4
n-6/n-3 PUFA ratio 4.3 23.2 4.3 25.2 6.0 2 25.3
________________________________________________________________________________________
Serum lipids (mmol/L) 
TC 6.2 11.2 6.2 13.7 4.9 2 19.3
LDL-C 4.3 16.6 4.2 21.0 3.0 2 29.0
HDL-C 1.5 28.0 1.4 23.8 1.5 25.0
TAG 0.9 44.3 1.2 53.0 1.0 50.7
Fat intake (E-%) 38.1 17.3 39.1 18.3 35.2 18.0
P/S ratio 0.33 1 40.9 0.47 40.3 0.43 45.0
Age 45.1 45.1 38.1
Men/women 21/22 25/21 11/37
_________________________________________________________________________________________
Unpaired t-test: 1 p<0.001, butter vs margarine users; 2 p<0.001, between margarine users
Comparison between the two groups of margarine users show especially high 
arachidonic (AA) and low docosahexaenoic acid (DHA) levels (p<0.001) in
Study 2. The fact that most of the subjects did not use fish in their habitual
diet is reflected by the higher PL n-6/n-3 PUFA ratio (p<0.001). In addition, 
the group was younger, consisted mainly of women, and had a lower fat 
intake, and clearly lower serum cholesterol levels (p<0.001) (Table 8).
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Quantitative variation of plasma lipid classes were examined in Study 2 (V). 
PC (mean 3.27 g/L) was the most abundant lipid class, ranging from 1.73 to 
5.60 g/L (27.3%, RSD). CEs were less variable (2.21 g/L; 18.9%, RSD) than 
FC (30.9%, RSD). TAGs had the highest relative variation (51.7%, RSD) and
corresponded to the levels obtained by the enzymatic method. 
5.3. Effects of fat substitutions on serum lipid levels and plasma fatty 
acid composition 
5.3.1. Replacement of butter by rapeseed oil (II)
Intake of substitute oil. Based on the dietary data, the average consumption 
of rapeseed oil in the group (n = 20) was 18 g/day, accounting for 20% of the 
total fat intake (II, Table 3). The doses did not exceed 40 g/day (Seppänen-
Laakso et al., 1989a). The P/S ratio of dietary fat increased (p<0.01) due to
the fall in SaFAs (p<0.01) and rise in PUFAs (p<0.01) (II). The proportion of
MUFAs (p<0.05) also increased. In the control group (n = 11) no changes 
were found in the nutrient intake. 
Total plasma fatty acids. As a result of reduced use of butter the proportion 
of SaFAs decreased by 4%-units, reaching its lowest level at 6 weeks (II, 
Table 4) (Fig. 4a). α-LLA increased during the rapeseed oil diet (p<0.001) and
decreased to the baseline at the end of the study (Fig. 4b).
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Fig. 4. Changes in plasma SaFA (a) and α-LLA (b) levels during fat replace-
ment.
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The mean intake of α-LLA was calculated to be 1.8 g/day, covering about
2.0% of total fat (II). The rise correlated with the amount of oil used (r = 0.51, 
p<0.05). A marked increase in LA occurred at 6 weeks (II, Table 4; 5 %-units,
p<0.001), whereas that in OA remained minor. The changes in these fatty
acids in the control group were non-significant. 
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Plasma PL fatty acids. The proportions of SaFAs, i.e those of palmitic and 
stearic acids, as well as the concentration of LDL-C, decreased significantly 
during the first 3 weeks of rapeseed oil substitution (II, p<0.001) (Fig. 5a-b). 
Both SaFA and cholesterol levels were restored at 6 weeks but remained 
below the baseline at the end of the study. 
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Fig. 5. Changes in plasma PL SaFA (a) and serum LDL-C (b) levels. 
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Fig. 6. Changes in PL fatty acids when replacing butter by rapeseed oil. 
Rapeseed oil raised the levels of all the major n-3 PUFAs, i.e. α-LLA
(p<0.001), EPA (p<0.01), DPA (p<0.05) and DHA (p<0.001), during the first 3 
weeks. The levels of EPA, DPA and DHA remained significantly higher still at 
6 weeks (II, Table 5) (Fig. 6). The rise in n-6 PUFAs (p<0.001) did not occur
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until at 6 weeks, i.e. in LA (n.s.), HGLA (p<0.05) and AA (p<0.001), with a
simultaneous fall in MUFAs (p<0.001). 
Fatty acids in the plasma PC fraction were determined at the baseline and 
after 3 weeks' rapeseed oil substitution (n = 20). The sn-2 position mainly
consisted of LA (46%) and OA (30%). Substitution caused an increase in LA 
and EPA (p<0.05) levels, with a simultaneous decrease in SaFAs and OA 
(p<0.05). In the sn-1 position, characterized by palmitic (41%), stearic (22%) 
and OA (19%), no changes appeared during substitution (Seppänen-Laakso 
et al., 1993b). Drastic differences in LA and SaFA levels in the sn-2 position 
existed between men and women (VI, Fig. 13). In men, the proportion of 
SaFAs (palmitic and stearic acids) was about 1.7-fold compared to that in 
women.
Serum lipids. During rapeseed oil substitution, the decrease in the serum TC
concentration (range 5.4 - 8.4; mean 6.3 mmol/L) was 7.8% (p<0.01) at 3 
weeks and 3.0% at 6 weeks (II, Table 6). The reductions in LDL-C were 
13.4% (p<0.001), but only 6.4% (p<0.05) at 6 weeks due to strong restoration 
of the values (Fig. 5b). In subjects with initial TC levels higher than 6.0 
mmol/L, the fall in LDL-C at 3 weeks was 16.3% (p<0.01) (II) (Seppänen-
Laakso et al., 1989a). Fat replacement had no effect on HDL-C
concentrations. In the control group the changes in cholesterol levels 
remained minor (n.s.). A rise in serum TAG levels was found during the 
experimental period in both the substitution and control groups (p<0.05). 
5.3.2. Replacement of butter by margarine (II) 
Substitute fat intake. When replacing butter by the test margarine the daily 
dose was 23 g, on the average, accounting for 22% of total fat (II, Table 3, n = 
23). The nutrient data showed a rise in PUFAs (p<0.05) and in the P/S ratio 
(p<0.01), and a decrease in the amount of dietary cholesterol (p<0.05). The 
mean intake of LA derived from the test margarine was 6.5 g and that of 
18:1trans-fatty acids 3.7 g/day. 
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Total plasma fatty acids. The decrease in SaFAs (3.6 %-units, p<0.001), as 
well as the increase in LA (4.7 %-units, p<0.001), was strongest at 6 weeks
(II, Table 4) (Fig. 7a-b). During the post-experimental period, the LA level
remained higher (p<0.01) and that of SaFAs lower (p<0.001) than at the
baseline.
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Fig. 7. Changes in total plasma SaFA (a) and LA (b) levels during replace-
ment of butter by the test margarine. 
Phospholipid fatty acids. Replacement of butter by the test margarine 
resulted in a decrease in the level of SaFAs (p<0.01) at 3 weeks (II, Table 5),
but also in a partial restoration at 6 weeks. The proportion of n-6 PUFAs 
increased at 3 weeks (p<0.01) and remained elevated until the end of 
substitution. The changes in MUFAs and n-3 PUFAs appeared slight as in
total plasma. PL 18:1trans-fatty acids are described in section 5.3.7. 
Serum lipids. The serum TC (range 5.1–7.5; mean 6.1 mmol/L) and LDL-C 
levels fell by 6.3% (p<0.001) and 7.8% (p<0.01), respectively, during the first
3 weeks (II, Table 6). The values were restored at 6 weeks, but decreased 
again at 12 weeks. A temporary fall in HDL-C levels (p<0.05) occurred at 3
weeks.
5.3.3. Relationships between plasma PL acids and serum lipids (II) 
At the baseline, PL α-LLA was the only fatty acid closely associated with the 
LDL-C levels in the combined group of habitual butter users (r = -0.40, 
p<0.01, d.f.= 41) (II). During rapeseed oil substitution at 3 weeks, the rise in
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PL linoleic/stearic acid ratio was inversely related to the fall in TC (r = -0.71,
p = 0.01; II, Fig. 2a) in subjects with TC baseline values higher than 6.0 
mmol/L (n = 11). This was also the case between the rise in α-LLA and the 
fall in TC (r = -0.62, p<0.05). Between weeks 3-6, the increase in SaFAs 
correlated with that in TC (r = 0.58, p<0.01; d.f. = 18; II, Fig. 2c).
In the margarine group, the rise in PL linoleic/stearic acid ratio at 3 weeks 
similarly correlated with the fall in TC (r = -0.59, p<0.01, d.f. = 21; II, Fig.
2b). Between weeks 3-6, there was a close correlation between the rise in 
LDL-C and PL stearic acid (r = 0.51, p = 0.01; II, Fig. 2d).
5.3.4. Replacement of margarine by rapeseed oil (III) 
Intake of substitute fat. In the group replacing margarine, the amount of 
rapeseed oil used was 17 g/day, accounting for 15% of the total fat, on the 
average (n = 23; III, Table 3). No changes were found in dietary cholesterol 
levels, whereas the P/S ratio increased during substitution (p<0.05) owing to 
the rise in PUFAs (p<0.01).
Total plasma fatty acids. The changes in plasma MUFAs appeared to be the 
best indicator of a reduced use of margarines (Fig. 8a) containing about 40% 
MUFAs (III, Table 2). The level of α-LLA increased during substitution
(p<0.01; III, Table 4) (Fig. 8b), and decreased to the initial level at the end of 
the study. The rise was dose-dependent (r = 0.79, p<0.001). 
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Fig. 8. Changes in total plasma MUFAs (a) and α-LLA (b) during replacement
of margarine by rapeseed oil. 
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The average intake of α-LLA derived from rapeseed oil was calculated to be 
1.6 g/day, which corresponded to 1.5% of total fat and 0.7% of the total 
energy intake. Compared to the baseline, the level of n-6 PUFAs remained
higher (p<0.001) and that of SaFAs lower (p<0.001) at the end of the study. 
Phospholipid fatty acids. Replacement of margarine by rapeseed oil caused a 
fall in palmitic acid (p<0.001), total SaFAs (p<0.001), AA (p<0.01) and total
n-6 PUFAs (p<0.01) during the first 3 weeks (III, Table 5) (Fig. 9). At the same 
time, α-LLA (p<0.001), EPA (p<0.01), total n-3 PUFAs (p<0.01), OA and total 
MUFAs (p<0.001) increased, whereas no change occurred in the DHA levels.
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Fig. 9. Changes in PL fatty acid composition when replacing margarine by 
rapeseed oil. 
The level of n-6 PUFAs (both LA and AA) markedly increased between weeks 
3-6 (III, Table 5) (Fig. 9). Simultaneously, n-3 PUFAs remained lower than at 
3 weeks, while the proportion of MUFAs (p<0.001) strongly decreased below
the baseline.
Serum lipids. During rapeseed oil substitution, no change in TC levels (range 
5.0–7.7; mean 6.1 mmol/L, n = 23) was found, while HDL-C temporarily 
increased by 6% (0.08 mmol/L, p = 0.01) at 3 weeks (III, Table 6). The HDL-C 
/TC ratio increased during the 6 weeks' diet period. In subjects with baseline 
TC levels higher than 6.0 mmol/L (n = 13), the fall in LDL-C was 10% (p =
0.01) at 3 and 11% (p<0.01) at 6 weeks.
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5.3.5. Replacement of margarine by olive oil (III) 
Substitute fat intake. In the group replacing margarine (n = 23), the amount 
of olive oil used was 19 g/day, accounting for 18% of the total fat (III, Table
3). A fall in the level of dietary PUFAs (p<0.05) and an increase in that of 
MUFAs (p<0.01) occurred. No changes were found in the P/S ratio or in 
dietary cholesterol.
Total plasma fatty acids. Olive oil substitution decreased the level of SaFAs 
(p<0.001) and raised that of OA during the 6 weeks' substitution (p<0.001; 
III, Table 4). The intake of oil correlated with the rise in OA at 3 weeks (r =
0.41, p<0.05).
Phospholipid fatty acids. Substitution had no effect on SaFAs, but decreased
LA (p<0.01) and increased OA (p<0.01). The changes were the reverse for the 
whole study period (III, Table 5) (Fig. 10). A temporary rise in EPA at 3 weeks
(p<0.001) and in AA levels at 6 weeks were found (p<0.01).
-1.5
-1.0
-0.5
0.0
0.5
1.0
1.5
Baseline 3 weeks 6 weeks 12 weeks
Time
C
ha
ng
e 
in
 P
L 
(%
-u
ni
ts
)
**
** **
OA
LA
Fig. 10. Changes in PL linoleic and oleic acids during fat replacement. 
Serum lipids. In the olive oil group (TC range 5.0-8.0; mean 6.3 mmol/L) the 
LDL-C level temporarily decreased at 3 weeks (7.5%, p<0.01), while that of 
HDL-C remained unchanged (III, Table 6). In subjects with TC baseline levels
higher than 6.0 mmol/L (n = 13), the fall in TC was also significant at 3 
weeks (7%, p<0.01). TC and LDL-C levels decreased (p<0.01) and were below 
the baseline during the post-experimental period. 
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5.3.6. Relationships between plasma PL fatty acids and serum lipids (III) 
During replacement of margarine by rapeseed oil the increase in PL α-LLA at 
3 weeks was inversely associated with the decrease in TC levels (r = -0.42, 
p<0.05; III) and with that of LDL-C (r = -0.43, p<0.05; III, Fig. 3a). The rise in 
α-LLA was also related to the rise (2.1 %-units) in the HDL-C/TC ratio 
(r = 0.44, p<0.05; III, Fig. 3b). During olive oil substitution the increase in 
OA at 3 weeks was associated with the decrease in TC (r = -0.59, p<0.01)
and LDL-C levels (r = -0.46, p<0.05; III, Fig. 3c).
5.3.7. Changes in 18:1trans fatty acid levels in plasma phospholipids (IV) 
At the baseline, the PL elaidic acid (18:1n-9trans) level was higher in
margarine than in butter users (p<0.01; IV, Table 5), and the proportions of
both elaidic and vaccenic acids (18:1n-7trans) were inversely associated with
the HDL-C concentrations (p<0.05 and p<0.01, respectively).
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Fig. 11. Changes in PL elaidic (18:1n-9trans; filled dots) and vaccenic acid
(18:1n-7trans; open dots) levels during replacement of butter
bytest margarine (a) and margarine by olive oil (b). 
During replacement of butter by the test margarine, the average intake of 
18:1n-11 to n-7trans-isomers was 3.7 g/day. The use of margarines was
best indicated by a rise of elaidic and vaccenic acids (IV, Table 5) (Fig. 11a).
When margarines (8% 18:1trans-fatty acids, on average; IV, Table 2) were 
replaced by olive oil, the proportions of PL elaidic and vaccenic acids
decreased during substitution (Fig. 11b). 
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5.4. Effects of fat substitutions on plasma lipid classes (V)
5.4.1. Effects of rapeseed and soybean oils 
Substitute fat intake. In Study 2 (V), the average amounts of cold-pressed (17 
ml; n = 26) or conventional rapeseed oil (15 ml; n = 16) or soybean oil (16 ml;
n = 6) accounted for 24% of daily fat intake during fat replacement. 
Lipid levels. The average serum TC concentration of the subjects was 4.9 
mmol/L (range 3.3 - 6.9 mmol/L; n = 48), but only slight changes (n.s.) were 
found in the groups during the 6 weeks’ substitutions. The concentrations of 
the major plasma lipid classes, i.e. CE, FC, TAG and PC, were determined by 
HPLC before and after substitutions.
Soybean oil raised the CE (n.s.) and reduced the FC levels (p<0.05), resulting 
in a rise in the CE/FC ratio (from 3.6 to 5.1, p<0.01). In the groups using
rapeseed oils the CE/FC ratio remained unchanged, whereas cold-pressed 
rapeseed oil more clearly increased the PC concentration (p<0.01) (V, Table
5). In addition, it reduced the non-lipidic compound fibrinogen (p<0.01).
5.4.2. Relationships between plasma lipid classes and PL fatty acids
In the whole group (n = 48), the PC concentrations at the baseline had a 
positive correlation with HDL-C (r = 0.51; p<0.001), plasma PL EPA (20:5n-3; 
r = 0.41, p<0.01) and MUFA (r = 0.41, p<0.01; V, Table 4). The increases in 
PC levels seemed to occur parallelly with those in n-3 PUFAs (p<0.05) during 
rapeseed oil substitutions (V, Table 5). PL LA, in contrast, had the highest 
inverse relationship with the PC concentration (r = -0.48; p<0.001; V, Table
4). Furthermore, LA was closely associated with FC (r = -0.56, p<0.001; V, 
Table 4) and it had, rather than serum lipids, an even closer relationship 
with the plasma esterified/free cholesterol ratio (CE/FC) (r = 0.65, p<0.001,
Table 5).
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6. DISCUSSION 
The fatty acid composition of dietary fat is decisive in the prevention of a 
variety of adverse or even serious health effects. The diet has to contain more 
linoleic (LA, 18:2n-6) than α-linolenic acid (α-LLA, 18:3n-3), and both of 
them in sufficient amounts because they cannot be synthesized by the body. 
Continuous interactions take place in their metabolism to longer-chain n-6 
and n-3 PUFAs because they compete for the same desaturating and
elongating enzymes. Thus, the effects depend on the ratio between these two 
dietary fatty acids (Holman 1986; Lands et al., 1992; Chapkin 2000). 
Major vegetable oils containing marked amounts of PUFAs also have the 
lowest levels of SaFAs. Although they are effective in replacing SaFAs, the 
majority of these edible oils have a high LA content (>50%) (Table 1) and 
thus the effects are due to n-6 PUFAs only. Among the MUFA oils, olive oil is 
rich in oleic (71-77%) but low in LA (7-10%). Canola-quality rapeseed oil is 
another high-MUFA oil, but contains moderate amounts of PUFAs in a more 
balanced ratio (LA, 18-23% and α-LLA, 9-11%). 
The desirable effects of the α-LLA of edible oils and long-chain n-3 PUFAs of 
marine foods, demonstrated already decades ago, are now receiving ever
more increasing attention in the prevention of cardiovascular disease (de 
Lorgeril et al., 1994; Leaf and Kang 1998; Simopoulos 1998; Lands 2003).
In the present investigation, the effects derived from partial replacement of 
dietary fats on the plasma fatty acid composition, lipid class and serum lipid 
levels, and their associations, were examined in two studies consisting of 
100 and 48 subjects, respectively. Substitute fats including ordinary (II-III, 
V) and cold-pressed (V) rapeseed oils, a test margarine (II, IV), olive oil (III-IV) 
and soybean oil (V), were used in amounts corresponding to the amount of 
fat on bread in the subjects' habitual diets. Fatty acids and lipids were in 
most cases measured at the baseline and after 3 and 6 weeks' substitutions. 
The methodology related to the GC of fatty acids and HPLC of lipid classes 
was optimized (I, IV, V). 
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6.1. Plasma fatty acid analysis by gas chromatography
Gas chromatography is an indispensable method in the fatty acid analysis of 
food fats and human tissues. Reproducible GC techniques and sample 
preparation procedures are required for the reliable determination of fatty 
acids over wide concentration ranges in plasma. The first steps usually 
include lipid extraction, isolation of lipid subclasses by TLC, derivatization of
fatty acids to methyl esters and, if required, TLC separation of cis/trans-
isomeric fractions. In the GC method, after selecting the carrier gas and an 
analytical column with sufficient resolution, optimization of the temperature
programming, injection modes suitable also for dilute samples, gas flow rates 
and split conditions is necessary (Shantha and Napolitano 1992; Eder 1995;
Ackman 2000a). Methodological points included in this study have also been 
treated in VI. 
The total plasma and plasma PL fatty acid composition were analysed by GC
using the PTV sampling technique with a mean reproducibility of 2.4 and
3.9% (RSD), respectively (I). Reliable analyses were needed for the main PL 
SaFAs (2%, RSD) even, because the methodological variation of palmitic acid, 
e.g. out of the total variation of the study subjects, accounted for as much as 
20% in single measurements (I) and 30% within a two-week period (Fig. 3).
A low relative variation of palmitic acid in plasma PL (I, 5.2% RSD; n = 100) 
seems to be typical, since similar values have been found, for example, in
populations of men (5.1%, n = 103; Nikkari et al., 1983a) and even children 
(4.1%, n = 162; Nikkari et al., 1983b). However, differences in PL SaFA levels 
caused especially by their long-term excessive intake, can be detected in 
lipids where they usually do not occur in abundance, as in plasma PC 
subfraction (Seppänen-Laakso et al., 1993b; VI, Fig. 13). The differences 
between groups at plasma PL n-3 and n-6 PUFA levels were usually very 
small, often 1-2 %-units only (Table 8). The changes in PUFAs but also in
octadecenoic trans-isomeric levels, although remaining clearly below 1 %-
unit during the fat substitutions (II-V), could be still reliably determined.
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6.2. Fatty acids as indicators of dietary fat intake
The changes made in the quality of dietary fat are best identified in the
plasma fatty acid composition, and fatty acid analyses are therefore 
necessary to ensure compliance with the fat substitution. However, the 
responses at the plasma level which are derived from dietary fat replacement 
can vary markedly depending on the age of the subjects, quality and 
quantity of fat, especially the amount of SaFAs in long-term habitual diets, 
fatty acid composition of the substitute fat, degree of fat replacement and the 
time period between the measurements on plasma lipids. It is therefore clear
that the detailed responses can be very different (VI). 
Saturated fatty acids. A high amount of SaFAs in the diet is the most 
adverse, and it is usually first evident as elevated serum cholesterol levels. 
When studying the effects of substitute fats, a clear-cut reduction in the 
plasma SaFA levels is required. However, decreasing trends are not always 
exactly the same in the different lipid fractions. 
In the present study (II), the replacement of butter by canola oil indicated a 
90% reduction of SaFAs on bread. The decrease in total plasma SaFAs (4 %-
units) (II, Table 4) (Fig. 4a) was most prominent at the end of the 6-week
period, thus definitely reflecting the reduced use of butter. A similar 
decrease in SaFAs was also observed when the test margarine was used (Fig. 
7a). When margarine on bread was replaced, the olive oil substitution 
brought about a fall in total plasma SaFAs (III, Table 4). 
The changes in SaFA levels were more complex in plasma PLs, but they also 
correlated with the cholesterol levels (II). When butter was replaced by
rapeseed oil, the lowest levels of PL SaFAs (-3 %-units; II, Table 5) and serum 
LDL-C (-13%; II, Table 6) were found at 3 weeks, because SaFAs were
restored by 1.3 %-units and LDL-C by 8.2%, respectively, during the 
following 3 weeks. The corresponding values in the margarine group were 
0.8 %-units and 4.6%. In both groups, the decrease in cholesterol levels at 3 
weeks was most closely related to the increase in the linoleic/stearic acid
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ratio (p?0.01), while the increase in cholesterol levels during restoration 
correlated with those in PL SaFAs, and especially in stearic acid (p?0.01) (II, 
Fig. 2c-d).
The restoration of LDL-C observed in the habitual butter users (II), but not 
in the margarine users (III), is evidently related to cholesterol metabolism 
and LA. The increase of LA in total plasma of about 5 %-units (II, Table 4) 
represented the largest change derived from substitute fats found at the 
plasma level in these experiments. As shown by the strikingly parallel trends 
for PL SaFAs and LDL-C (Fig. 5a-b), the changes between weeks 3 and 6 can 
be considered as indicators of long-term accumulation of cholesterol (and
SaFAs) in the body under a shortage of dietary LA, and their release from the 
tissues into the plasma during fat substitution (VI). A similar phenomenon is 
known in the opposite case too, i.e. when the preceeding diet is high in LA. 
Adipose tissue LA can be a continuous source of LA to tissue PLs when the 
intake of this fatty acid is restricted (Mantzioris et al., 1995). 
Replacement of margarine by rapeseed oil, which also first reduced the PL 
SaFA levels (~2 %-units), led to a SaFA restoration at 6 weeks (1.3 %-units) 
(III, Table 5). This shows, despite the use of margarine on bread, that
marked amounts of SaFAs have also been included in the diet of habitual 
margarine users. The fact that the decrease in PL stearic acid, instead of 
palmitic acid, most often correlated with that in TC when replacing butter by 
rapeseed oil (II), reflected the early features of Finnish high SaFA diets. In 
the adipose tissue of men, the stearic acid level especially has earlier been
shown to be twice as high, and that of LA about half of that in Italian men 
(Riemersma et al., 1986).
The plasma PC fraction was the most indicative of an imbalance between LA
and SaFAs (Seppänen-Laakso et al., 1993b; VI, Fig. 13). In the group of men, 
both stearic and palmitic acids were responsible for lower proportions of LA
in the sn-2 position of PC. A sufficient LA level is important due to its 
relation to cholesterol metabolism, because LA in this position is the best 
substrate for HDL-associated LCAT to esterify cholesterol which, in turn, can
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perform the reverse cholesterol transport from peripheral cells to the liver 
(Jonas 1987).
Trans-fatty acids. High amounts of 18:1trans-fatty acids also represent an 
undesirable component of food fat, the main sources being food products to 
which partially hydrogenated fats have been added. They represent about
0.3-3% of total fatty acids in human fat tissue (Ohlrogge et al., 1982;
Fritsche et al., 1998). The profiles of 18:1trans-isomers have been
determined in various lipid classes in several human tissues, most often in 
plasma (Ohlrogge et al., 1982; Emken et al., 1989a, 1989b) and adipose
tissue (Hudgins et al., 1991; Fritsche et al., 1998).
Changes in the plasma PL 18:1trans-isomeric level were studied by replacing 
trans-containing margarines by vegetable oil, or by replacing butter by a 
trans-containing test margarine (IV). At the end of the 1980s, many of the
margarines contained about 8% of 18:1trans-isomers (IV, Table 5). The two 
major isomers, elaidic and vaccenic acids, were excellent indicators in that
they clearly indicated both decreased and increased use of trans-fatty acid-
containing fats (Fig. 11). Despite the low levels of these isomers in plasma PL 
(<1%), they were inversely associated with HDL-C when the habitual diets 
contained hydrogenated fats.
One specific feature is that the trans-pattern of dietary fat is not reflected as 
such in plasma PLs (Ohlrogge et al., 1982; Emken et al., 1989b). The
isomeric profiles demonstrate that the incorporation of elaidate (18:1n-
9trans) derived from hydrogenated fats is particularly efficient compared to
the other isomers (IV, Fig. 1). Based on the elaidate level, the isomeric profile
is different from that derived from butterfat, and this can also be clearly 
distinguished by direct GC analysis of the plasma PL fraction (IV, Fig. 2). 
Major unsaturated fatty acids. The fatty acid composition of adipose 
tissue, the principal site of the storage of body fat, provides suitable 
biomarkers of dietary fat quality during long periods of time (Katan et al., 
1991; Marckman et al., 1995; Lands 1995). Dietary fat is mainly composed
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of TAGs, and it is therefore the most variable lipid class in plasma, the 
concentrations varying even within a tenfold range (V). Thus, the TAG
fraction as well as total plasma (I-III), in addition to giving the average fatty
acid composition of lipids, can also be used in monitoring dietary fat intake. 
The cholesteryl ester (CE) fraction is a suitable indicator for LA, since it is 
especially enriched in this lipid class. Early studies have compared CE LA 
levels in free-living populations of Finnish men (Nikkari et al., 1983a), in 
children using butter or margarine on bread (Nikkari et al., 1983b), and in
North Karelians consuming sunflower oil diets (Nikkari 1986). CE α-LLA is a 
suitable indicator for rapeseed oil-based diets (Sarkkinen et al., 1994; Valsta 
et al., 1995), as well as LA for rapeseed oil and sunflower oil diets (Valsta et
al., 1995). In a long-term intervention study on children, clearly higher CE
LA but lower long-chain n-6 and n-3 PUFA levels were indicative of formula-
fed infants compared to breastfed 7-month-old infants (Salo et al., 1999). 
After the intervention families had been counselled to replace part of 
saturated fat with more unsaturated fats, higher PL MUFA levels without 
any differences in PL 18:1trans-fatty acids were found in the intervention
and control children at the age of 3 years (Salo et al., 2000). 
Total plasma α-LLA was the best indicator of the course of the substitutions 
when butter or margarine were replaced by rapeseed oil (Fig. 4b, 8b) (II, III
Fig. 2a). The daily doses of the oil, containing 1.8 and 1.6 g α-LLA, correlated 
with the rise in α-LLA. The dose of olive oil (19 g/day) also correlated with 
the increase in total plasma OA (III, Fig. 2b), while a rise in PL OA occurring
at the expense of LA was indicative of the dietary change (VI, Fig. 7).
The control subjects (n = 11) who were asked to continue their habitual diets 
proved to be useful in monitoring seasonal changes in plasma lipid and fatty 
acid levels from February to May. However, no marked changes were found 
in the control group during the first 6-week period (II).
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6.3. Competitive interactions caused by essential fatty acids in the diet 
Competitive mechanisms are known to arrange the priority of unsaturated 
fatty acids. The enzyme-substrate affinities, which follow the order linolenic 
(n-3) > linoleic (n-6) > oleic acid (n-9), indicate that when linolenate is
present in the substrate pool, its conversion to higher unsaturated fatty 
acids takes precedence over the metabolism of linoleate (Holman and
Mohrhauer 1963; Mohrhauer and Holman 1963). An opposite effect has also
been found, i.e. increasing the amounts of dietary linoleate suppresses the 
levels of linolenate metabolites (Rahm and Holman 1964).
The changes found in PL fatty acid levels after ordinary fat replacement (II,
III) can be explained by the differences in the incorporation and desaturation
of precursor α-LLA (18:3n-3) and LA (18:2n-6) and subsequent interactions
between the three unsaturated (n-3, n-6, n-9) fatty acid families. This
presupposes that substitute fat contains at least moderate amounts of both
α-LLA (10%) and LA (24%) as was the case in this study in rapeseed oil.
Since the composition of the substitute fat corresponded to that of the oil, 
the effects can be attributed to the oil itself. 
Replacement of butter by rapeseed oil (II). This study shows, for the first
time at the plasma PL level, a preference for α-LLA and its n-3 PUFA 
metabolites over LA and its n-6 metabolites during vegetable oil substitution. 
In addition, the subsequent increase in n-6 PUFAs did not affect the elevated 
n-3 PUFA levels (II, Table 5) (Fig. 6). Thus, only PUFAs increased when
butter was replaced by rapeseed oil. 
In plasma PL, substitution indicated an increase in all the major long-chain 
n-3 PUFAs during the first 3 weeks and, simultaneously, a clear reduction in 
PL SaFAs (II, Table 5) (Fig. 6). A marked rise in PL n-6 PUFAs was not seen
until at 6 weeks, and the level of monoenoic OA (18:1n-9) fell even. Thus, the 
main compound in rapeseed oil (OA, 60%) could not limit the incorporation 
of PUFAs in plasma PL during substitution.
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A time gap also existed between the changes, but this may not exactly 
indicate when PL n-3 and n-6 PUFAs are reaching their maximum levels.
However, in these measurements, the rise in n-3 PUFAs (1.7 %-units) at 3 
weeks was higher than that in n-6 PUFAs (1.1 %-units) (II, Table 5). Thus, it 
is clear that the conversion of α-LLA is faster than that of LA, and that an 
increase in long-chain n-3 PUFAs (EPA, DPA and DHA) can cause a delay by 
suppressing the conversion of LA to its longer-chain metabolites. 
The metabolic preference for n-3 PUFAs is in accordance with in vivo studies
using deuterated precursors (Emken et al., 1989a, 1992; Chapkin 2000). 
Although α-LLA is considerably less effectively incorporated into plasma PL, 
it has a clearly higher desaturase selectivity for conversion to long-chain  n-3
PUFAs than LA has for conversion to n-6 PUFAs. Incorporation of LA, in
turn, is much higher than that of α-LLA, as has been shown in the main 
lipid fraction of plasma PL, phosphatidylcholine (PC) (Emken et al., 1992).
During replacement of butter by rapeseed oil (II), moderate amounts of LA 
(24%) appeared to be appropriate (not too high), since no suppressive effect
of n-6 PUFAs on n-3 PUFAs was found in plasma PL at the end of 
substitution (Fig 4). However, activated LA metabolism led to a considerable 
decrease in MUFAs (OA), showing that even a high OA level in dietary fat is 
not able to suppress the effect derived from moderate amounts of LA. The
suggestion that OA is a neutral fatty acid in its relation to serum cholesterol 
(Keys 1957; Hegsted et al., 1965) seems to be the case during competitive
processes when both EFAs become sufficiently available in high SaFA diets. 
Replacement of butter by the test margarine (II). The effects were very
different when the substitute fat contained 28% LA and 3% α-LLA acids. An
increase in PL LA and AA levels already at 3 weeks showed no delay and 
response caused by n-3 PUFAs, but predominant n-6 PUFA effect for the 
substitution period (II, Table 5). This would indicate that dietary fat with a 
low α-LLA and moderate LA content, has no recognizable effect of n-3 PUFAs 
in plasma PL. 
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Replacement of margarine by rapeseed oil (III). The contents of SaFAs 
and LA in habitually used margarines were about 24 and 31%, respectively. 
Therefore, the change in fat on bread was not very drastic, and it was best
reflected in plasma PL. During the first three weeks, when both SaFAs and
LA decreased, there was not only an increase in α-LLA and EPA, but also in 
MUFAs (1.9 %-units) (III, Table 5). Figure 9 shows that the rise in n-3 PUFAs 
replaces the fall in n-6 PUFAs, and that MUFAs seem to compensate for 
SaFAs. Thus, reducing SaFAs and LA results in an increase in EPA and
MUFAs especially, and apparently without interferring with each other. At
least one study with subjects comparable to the present group reported very
similar data as regards changes in PL SaFAs, MUFAs, n-6 PUFAs and EPA
after a 3-week rapeseed oil-based diet (Gustafsson et al., 1994). 
The dominant role of LA in the middle of the competitive ranking becomes 
evident when margarine replacement is continued (III, Table 5). The fact that
a rise of 2 %-units in PL n-6 PUFAs did not occur until between weeks 3-6
means that LA from the rapeseed oil had started to be utilized (Fig. 9), but it 
had also a strong suppressive effect on n-3 PUFA metabolism and MUFA 
levels (-2.8 %-units). In fact, PL DHA (22:6n-3) in this group never increased
as a result of α-LLA, which has earlier often been reported for this fatty acid. 
However, elevated levels in all the long-chain n-3 PUFAs during rapeseed oil 
substitution (II) show that this is not due to the weakness of α-LLA
conversion, but rather the higher LA intake in the diet of habitual margarine 
users.
Effective α-LLA conversion to EPA, confirmed as an increase of ca. 25%, but 
not to DHA (III, Table 5), may also include retroconversion of DHA to EPA.
Metabolism directed entirely to EPA can be seen as a protective mechanism 
to maximize the antithrombotic state when the thrombotic effects of linoleate 
/arachidonate/TxA2 pathway are continuously active. As EPA has a number 
of unique pharmacological and biochemical actions, it is assumed that DHA, 
via retroconversion, supplies EPA on demand when the supply of α-LLA is
inadequate (Nelson 2000).
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Associations with plasma lipid classes (V). Linoleic acid is predominant 
also in its relationships with free cholesterol (FC) (r = -0.56; n = 48; V, Table
4) and PC concentrations (r = -0.48), and with the relation of CE to FC. At
the baseline, PL LA rather than serum lipids showed a close link to 
cholesterol metabolism on the basis of its high correlation with the CE/FC
ratio (r = 0.65, p<0.001). In a subgroup of subjects already having elevated 
levels of n-6 PUFAs in plasma PL (Table 8), the high LA content (55%) in
soybean oil had a strong effect by further raising the n-6 PUFAs, as well as 
the CE/FC ratio (V, Table 5).
A high proportion of the high-density lipoprotein cholesterol (HDL-C) fraction 
in serum lipids is desirable due to its antiatherogenic properties (Miller and 
Miller 1975). In HDL, PC is a rich lipid fraction (Hemming and Hawthorne 
1996), and plasma concentrations are closely related with the ratio of HDL-C 
to total cholesterol (V, Fig. 3). However, PC correlated positively not only with 
HDL-C (r = 0.51; V, Table 4), but also with PL MUFAs (r = 0.41) and n-3 
PUFAs, especially EPA (r = 0.41). All the associations of LA were opposite to
those of n-3 PUFAs. LA can easily suppress n-3 PUFAs and thereby reduce 
HDL-C, which has been reported after a high intake of LA (Vessby et al.,
1980; Mattson and Grundy 1985). Despite a slight effect on serum lipids, the 
plasma PC levels were raised more clearly by cold-pressed than by ordinary 
rapeseed oil substitution (V, Table 5), while both oils showed similar trends 
by increasing EPA and decreasing the n-6/n-3 PUFA ratio in plasma PL. 
The fat substitutions used in the present study indicate that the α-LLA and 
LA contents in rapeseed oil are high enough to give priority to proper n-3
and n-6 PUFA metabolism. LA already in moderate amounts gives a 
significant response when reducing a high-SaFA dietary fat. It is important
that both EFAs can be obtained from the same vegetable oil, as this is the
easiest way to fulfil the requirements of α-LLA and LA, and to maintain the 
balance of n-3 and n-6 PUFA metabolism.
It was also evident that the effectivity of α-LLA vs LA can be largely estimated 
on the basis of their relative amounts, i.e. percentages in a specific dietary 
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fat. When health claims for fatty acid compositions are presented, rapeseed 
oil should be the basis for comparison.
Rapeseed oil is, so far, the most balanced vegetable oil and a visible fat 
highly necessary for western-type diets that is capable of normalizing EFA
metabolism. The basic functions of EFAs regulated by competitive 
mechanisms of the body have to be taken into account in long-term 
prevention and in the treatment of diseases that can be partly derived from 
imbalances in dietary fat composition. 
6.4. Dietary fats and lowering the risk of CHD 
N-3 PUFAs and populations with low CHD. The highly different sources 
and quality of fats in traditional diets in populations with a low rate of CHD
have always appeared controversial. The Cretan diet mainly contained olive 
oil (Keys 1970), which is high in MUFAs but practically free of n-3 PUFAs (α-
LLA), while the diet in Greenland Eskimos was based on seafoods (Bang et
al., 1971) containing long-chain n-3 PUFAs. Thus, the fat in these diets had 
to include some basic properties that afforded protection against CHD. Such
an effect could be due to the functions of n-3 PUFAs, combined with an
abundance of MUFAs in the diet (Simopoulos 1998; Lands 2003). 
The food fat in the traditional diets of the Eskimos was unexpected rich in
MUFAs (57%), contained half the LA and 2/3 of the SaFAs in the western-
type Danish diets, while the contents of n-3 PUFAs i.e. EPA and DHA, often 
expected to be exceptionally high, were both about 2 %-units. However, they 
were 6-fold compared to those in Danish foods (Bang et al., 1976). The term
'traditional Mediterranean diet' has a specific meaning that reflected food
patterns typical of Crete, much of the rest of Greece, and southern Italy in 
the early 1960s (Willett et al., 1995). Green leafy vegetables and wild plants 
at that time formed a significant source of n-3 PUFAs (α-LLA), which could
also be seen as elevated serum α-LLA levels (Simopoulos 1998). The Cretan
diet thus reflected how effective an n-3 PUFA metabolism, supported by a 
high MUFA intake, could be achieved on the basis of the food intake. The
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conversion of α-LLA is expected to proceed normally when combined with low 
SaFA and rather low LA contents (Renaud et al., 1995; Simopoulos 1999).
The present study also showed that the conversion of α-LLA to EPA was best 
enhanced when both SaFAs and LA were reduced, i.e. by replacing
margarine by rapeseed oil (Fig. 9). High amounts of OA in the oil caused a 
strong rise in PL MUFAs, but did not limit effective conversion of α-LLA to 
EPA (III). Olive oil substitution, instead, had a clear LA-reducing and MUFA-
raising effect (Fig. 10). Olive oil may favour the conversion of α-LLA obtained 
from other dietary sources as in the early Mediterranean diets (Simopoulos 
1998).
The fat in the traditional diet of the Eskimos was a natural part of marine 
foods, while the Mediterranean diet was characterized by vegetable-based 
foods with an oily visible fat, olive oil. These diets had apparent health
benefits but only when followed strictly, and there have since been clear
changes towards more western-style diets (Ferro-Luzzi et al., 1984; Dewailly
et al., 2003). Plasma TC, blood pressure and obesity in Cretan men, for
example, increased between 1960-90 (Kafatos et al., 1997), and similar TC
levels exist even among Cretan, American and Dutch children (Truswell and 
Choudhury 1998). In elderly Greeks, a higher risk of death was reported 
among those whose diets deviated the most from the traditional ones 
(Trichopoulou et al., 1995).
Linoleic acid in the diet. LA is the primary EFA which is ubiquitous in the
diet. Early animal studies showed that LA metabolism is predominant, as 
indicated also by its location in the middle of the competitive order: α-LLA
(n-3) > LA (n-6) > OA (n-9) (Holman and Mohrhauer 1963). In the case of a
complete lack of EFAs, reported once also in the human diet (Holman 1968), 
the ultimate attempt of the body is to synthesize PUFAs from OA. Similar 
selectivities of the metabolic systems of EFAs also appear in human tissue 
PL (Lands et al., 1992). On the basis of empirical equations, long-chain n-3
and n-6 PUFA levels in PL were shown to be in a competitive, hyperbolic 
relationship to the dietary supply of their precursors. Incorporation of α-LLA
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and LA into tissue TAGs, in turn, follow a linear equation (Lands et al., 1992;
Lands 1995, 2000). 
During ordinary fat replacements, competitive interactions were also evident 
in the plasma PL fatty acid composition, and LA proved to be responsible for 
the most marked changes in the unsaturated fatty acid families (II, III, V).
The rise in total plasma α-LLA best correlated with the daily dose of rapeseed
oil, and clear effects derived from both α-LLA and LA metabolism were 
observed in plasma PL n-3 and n-6 PUFA levels (II, III). 
The proportion of LA in the diet is highly critical. For example, a low intake 
and low tissue levels have been found to be characteristic in populations 
with high CHD (Riemersma et al., 1986), while an excessive intake can result 
in increased LDL oxidation (Reaven et al., 1991, 1993; Louheranta et al., 
1996). These effects clearly reflect the highly variable LA contents in dietary
fats. Early Finnish studies demonstrated regional differences even in serum
LA levels (Nikkari et al., 1983a). There were drastic differences compared
with Swedish populations, which showed 10 %-units higher serum LA levels 
than men living in eastern Finland (Nikkari 1986). There was also a clear
difference in the use of margarines, (18 kg/person/year; 1970) vs that in
Finland (7 kg/person/year; 1970) (Trygg 1991), suggesting a much longer 
history of sufficient amounts of LA in Swedish diets. For comparison, CHD 
mortality in men in Sweden in 1985 was only 60% of that in Finland (Trygg
1991). Since the 70s, the intake of LA in Finland has started to increase 
along with the use of margarines. 
The fat replacements used in these studies showed that already moderate 
amounts of LA in dietary fat can be sufficient for marked responses at the
plasma PL level (II, III). During rapeseed oil substitution, the intake of LA
was apparently closest to the optimum, because the LA supply did not
suppress the previously increased levels of PL n-3 PUFAs (II). In addition,
moderate amounts of EFAs may not markedly affect lipid oxidation, as has 
been reported by studies on rapeseed oil (Corboy et al., 1993; Turpeinen et
al., 1995; Södergren et al., 2001).
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Dietary n-3/n-6 PUFA balance. In early Finnish studies, attention was 
already paid to the ratio of n-3 and n-6 PUFAs, and to the fact that the role 
of LA-rich fat in reducing lipid levels did not necessarily mean favourable 
platelet functions in the absence of an adequate supply of n-3 PUFAs (Salo et
al., 1985). The amount of LA appeared to be significant when a high LA 
intake reduced n-3 PUFAs, especially EPA, by strong competitive effects 
(Nikkari 1986). In a study in Finnish men, a low intake of unsaturated fatty 
acids, which was reflected as low levels of both n-3 and n-6 PUFAs in serum
PL, was found to be predictive for MI (Miettinen et al., 1982). 
In addition to the imbalance between a high SaFA and low LA intake, the 
other imbalance has been between a low α-LLA and high LA intake, known
for decades in some western-type diets, especially in the U.S. (Budowski et
al., 1984; Lands et al., 1992; Holman 1998; Chapkin 2000). Ignoring α-LLA
as an EFA, and emphasizing LA-rich vegetable oils as the only source of 
PUFAs and, if present, even removing the α-LLA, has been much criticized
(Holman 1998). α-LLA-deficient diets have been considered to be responsible 
for the very low PL n-3 PUFA levels in U.S. adults and newborn infants. 
A high n-6 PUFA intake increases n-6 eicosanoids; reducing their effects by 
dietary means can be achieved by increasing the intake of competing n-3
PUFAs (α-LLA, EPA, DHA) (Lands 2003). These, in turn, can be important in 
preventing cyclo-oxygenase from forming active n-6 eicosanoids in inflamma-
tion, thrombosis and arrhythmia. Choosing dietary fats to increase the n-3/ 
n-6 PUFA balance can be an effective primary prevention strategy to reduce 
the risk of fatal CHD events (Lands 2003). The proportions of long-chain
PUFAs have been shown to have a close relationship with CHD mortality 
rates (Fig. 2). 
Vegetable oils are the most important sources of EFAs, and modification of
oilseed fatty acid compositions by metabolic engineering would provide new 
possibilities for the development of more balanced α-LLA/LA ratios of dietary 
fats (Kris-Etherton et al., 2000). On the basis of the present study, moderate
amounts of both EFAs, combined with a high OA content, should be 
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preferred (II, III, VI). α-LLA, especially, has to be present in effective amounts 
to give priority to n-3 PUFA metabolism, as was found with rapeseed oil.
Fish foods provide ever-more significant sources of n-3 PUFAs for western-
type diets. Fish meals twice a week have also been shown to afford
protection against CHD (Kromhout et al., 1985). A clearly reduced CAD 
mortality has been reported in patients who had suffered an MI, and then
been advised to eat fatty fish (Burr et al., 1989) or EPA/DHA capsules (GISSI 
Prevenzione Trial, 1999). In a study in Finnish patients with established
CAD, higher CE EPA contents derived from fish intake was related to a lower
risk of CAD death, and higher α-LLA, EPA and DHA levels to a lower risk of
all-cause mortality (Erkkilä et al., 2003). It was recently stated that fish is 
more beneficial than fish oil (Marckman 2003). In contrast, an oil supply is 
important for patients with a history of coronary events, and those with
hypertriglyceridemia or rheumatoid arthritis. 
During the last decade, α-LLA containing vegetable oils and fats have 
become widely available, and increasing evidence of the inverse relationship
between CHD and α-LLA intake has been reported (de Lorgeril et al., 1994; 
Ascherio et al., 1996; Hu et al., 1999; Djousse et al., 2001; Lemaitre et al., 
2003). However, no such relationships with the intake of α-LLA from trans-
fatty acid-free foods have been found when the diet included LA-rich 
vegetable oils (Oomen et al., 2001). 
A statement by international workshop has pointed out the importance of
reducing n-6 PUFAs in order to reduce the adverse effects of excesses of AA 
and its eicosanoid products (Simopoulos et al., 1999). The presence of α-LLA
in the diet can inhibit the conversion of high amounts of LA in western-type
diets containing too much LA-rich vegetable oils (e.g. corn, safflower and 
soybean oils). An increase in α-LLA, together with EPA and DHA, are
necessary to achieve a healthier diet. Adequate daily intakes of EFAs and 
other PUFAs for adults were recommended to be 2.2 g for α-LLA (n-3), 4.4-
6.7 g for LA (n-6), 0.65 g for EPA+DHA (n-3) and 0.22 g (min) for both DHA 
and EPA (Simopoulos et al., 1999).
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A high LA intake is not a major problem in the Finnish diet, but rather a too 
high intake of SaFAs. The recommended ratio for α-LLA and LA was 1:2, as it 
is in rapeseed oil, and a clear PUFA effect was obtained with a mean daily 
dose of 18 g (II). This required a clear reduction of SaFAs, leading first to an 
increase in all the major n-3 PUFAs in plasma PL (EPA, DPA and DHA), 
following an increase in n-6 PUFAs (HGLA and AA). In contrast, no 
significant effects of EFAs can be expected from olive oil due to their low 
contents (Table 1), which are even lower than those in the best margarines
already at the end of the 50s (3% α-LLA; 12% LA) (Lampi et al., 1959).
Lowering SaFAs and cholesterol. Despite the decrease in the use of butter 
in the Finnish diet at end of the 80s, the positive trends have not continued,
and the intake of SaFAs is still too high. A reduced use of fish has also been 
reported (Männistö et al., 2003). The consumption of cheese, especially,
which is now the main source of hard fat in women's diets, has increased 
from 13 to 17 kg/person/year (Lahti-Koski and Kilkkinen 2001; Männistö et
al., 2003). It is also important to note that, unless varying fat contents (28-
80%), the proportion of SaFAs in spreads and margarines can range between
20-48% (Table 3) (Anon. 2003b). In addition, the use of vegetable oils (<5
kg/person/year) has increased by only 1 kg during the last decade (Lahti-
Koski and Kilkkinen 2001). 
Rapeseed oil has a clear plasma SaFA and cholesterol lowering effect (-13%, 
LDL-C) with a dose range of 10-40 g/day (II; Seppänen-Laakso et al., 1989a). 
Rapeseed oil (and the test margarine) also brought about cholesterol
restoration from tissues in habitual butter users (Fig. 5b) (II). The fact that
rapeseed oil did not cause a corresponding effect in habitual margarine
users (III), shows the importance of LA for cholesterol transport when
sufficient LA becomes available in habitual butter users. However, SaFAs 
were restored in all these groups. The fall in cholesterol depends on the 
SaFA content of the substitute vs replaced fat, and thus vegetable oils are 
the most effective. For example, the fat in spreads contains about 4-5-fold 
and that in butter 10-fold amounts of SaFAs compared to rapeseed oil
(Tables 3-4). 
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The use of vegetable oils, green vegetables, berries etc. is highly important to 
obtain antioxidant protection from vitamin E. Comparison of European 
populations, for example, has shown that Finnish men had the lowest 
plasma vitamin E levels and South-European men highest ones (Gey et al., 
1991). Similarly, the use of vegetable oils in Finland has been very low (2-3 
kg/person/year; 1981-95) (Anon. 1996) compared to the traditional use in
Italy (10-18 kg; 1963-65) (Ferro-Luzzi and Branca 1995). 
A recent study in Finnish men with cholesterol levels of 6.6 mmol/L 
indicated that, besides many desirable effects, a change to a modified 
Mediterranean-type diet may not be very effective in reducing SaFAs. This
was indicated by the relatively small decrease in LDL-C levels (-11%) (Jula et 
al., 2002). The impact of rapeseed oil when saturated fat mainly was
replaced (II) was clear even in a small subgroup (mean TC 6.8 mmol/L;
n = 11). An average fall in LDL-C of 16% was found already following partial
fat replacement with doses below 40 g/day (Seppänen-Laakso et al., 1989a).
The correlation in this group (II, Fig. 2a), which reflects the desired change in 
the dietary P/S ratio, also showed that an increase in LA is closely related to 
the decrease in TC, and that half of the reductions were between 10-25%. 
The fall in TC was 7.5-20% in the whole group, when butter was replaced by 
the test margarine with 28% of LA (n = 23) (II, Fig. 2b). 
Rapeseed oil with relatively high tocopherol content (Södergren et al., 2001) 
could make a significant contribution when combined with drug therapy. A
continuous supply of tocopherols would be beneficial, since simvastatin
treatment, after a strong reduction in cholesterol levels (21%), also decreased
the lipoprotein-bound α-tocopherol in plasma (Jula et al., 2002). Lovastatin, 
for example, is known to increase the desaturation of LA to AA, and 
thromboxane formation, in human hepatoma cells (Hrboticky et al., 1992). 
Therefore, vegetable oils with clear n-3 PUFA effects can be used to modulate 
the hepatic metabolism of n-3 and n-6 fatty acids. The conversion of α-LLA
to EPA to suppress n-6 PUFAs, thus providing a more desirable n-3/n-6 
PUFA ratio, is considered to have benefits for hypercholesterolemic patients 
(Hrboticky et al., 1996). 
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Besides the marked effects on plasma PUFA levels, the low SaFA content 
(6%) in rapeseed oil is especially effective when replacing visible saturated fat
(II). It is also evident that most of the elevated cholesterol levels are still 
caused by a too high intake of SaFAs in the Finnish diet. However, instead of 
using drugs, such cholesterol levels should be simply reduced by changing 
the dietary fat, primarily to rapeseed oil. Reducing SaFAs (II) and also LA (III) 
indicated a preference for α-LLA conversion to EPA over the metabolism of 
LA, which may partly improve the antithrombotic effects (McDonald et al., 
1989; Weaver et al., 1990). 
The fatty acid composition of rapeseed oil provides significant health benefits 
in dietary fats. Rapeseed oil should be a daily constituent in the diet to 
maintain better balance between PUFAs and SaFAs, and also between n-6 
and n-3 PUFAs, which can be expected to have important contributions in
the long-term prevention of many diseases. 
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7. CONCLUSIONS 
Gas chromatography (GC) using a programmed temperature vaporization
(PTV) is a reproducible method for fatty acid analysis, and is especially 
suited for detailed follow-up of the changes in plasma fatty acid composition 
during dietary fat replacement. A high performance liquid chromatographic 
(HPLC) method with evaporative light-scattering (ELS) detection proved to be
highly applicable in the analysis of plasma lipid classes for studying their
variation and associations with serum lipids and plasma fatty acids. 
Total plasma α-linolenic (α-LLA) and oleic acids (OA) were the best indicators 
of the use of rapeseed and olive oils, respectively, and also showed dose-
dependent correlations. When replacing fat on bread for six weeks, it was 
possible to monitor the changes in saturated fatty acid (SaFA) levels, the 
metabolism of essential fatty acids (EFAs) to long-chain polyunsaturated
fatty acids (PUFAs) and competitive interactions in the plasma PL fraction. 
The decrease in LDL cholesterol levels was most prominent during the first 
three weeks when high saturated fat (butter) on bread was replaced by 
rapeseed oil or margarine (13 and 8%, respectively). The decrease in
cholesterol levels most often correlated with an increase in the linoleic 
(LA)/stearic acid ratio in plasma PL, reflecting the desired change in the 
dietary PUFA/SaFA ratio. It was also indicative that SaFAs were enriched in
the phosphatidylcholine (PC) fraction, and excessive palmitic and stearic
acids were found in the sn-2 position. 
The partial restoration of cholesterol levels, which occurred in habitual
butter but not in margarine users at the end of the substitutions, was 
assumed to be due to the release of cholesterol from the tissues when 
sufficient LA became available in the diet. It was shown that plasma PL SaFA 
and stearic acid levels were also closely correlated with the rise in serum 
cholesterol levels. The results also suggested that most of the high 
cholesterol levels (mean 6.8 mmol/L) could be reduced (10-25%) by the use 
of rapeseed oil to replace visible high saturated fat. 
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An increase and a decrease in trans-fatty acid intake were clearly reflected at 
the levels of the most abundant octadecenoic trans-isomers in plasma PL.
Thus, undesirable effects related to high amounts of trans-fatty acids can be 
avoided simply by avoiding food products containing hydrogenated fats. 
Olive oil, which has no PUFA-raising effect, is basically a different vegetable
oil compared to rapeseed oil. Olive oil clearly reduced PL LA levels in
habitual margarine users, which can be desirable if their LA intake is high. 
However, n-3 PUFAs (α-LLA) still have to be obtained from other sources. In 
addition, some olive oils with very low LA contents (<8%) would be poor
sources of LA in typical high SaFA Finnish diets, for example.
The results showed a balanced metabolism of both α-LLA (n-3) and LA (n-6) 
after replacing high saturated fat by moderate amounts of rapeseed oil
containing 10% α-LLA and 24% LA. The changes in plasma PL fatty acid 
levels indicated a priority for desaturation of α-LLA to long-chain n-3 PUFAs
and marked competitive effects over LA and n-6 PUFA metabolism. These
interactions resulted in a rise in PL n-3 PUFAs, which was highest at 3 
weeks, while in n-6 PUFAs this was not reached until after 6 weeks, i.e.
there was a delay in the metabolism of LA.
Competitive interactions between fatty acids arise from the basic functions of
the body and, since ancient times, they have ensured priority for EFAs from 
foods. These aspects have to be taken into account in preventing a number 
of adverse health effects derived from the highly variable fatty acid 
composition of dietary fats. For instance, the decreasing trends in SaFA in
the Finnish diet have slowed down, reflecting that there is still a low 
consumption of edible oils. Oils should be the primary means of lowering 
elevated cholesterol levels, which are derived merely from incorrect fat and 
food choices, rather than the use of drugs with high public expense.
Rapeseed oil is widely recommended because of its moderate α-LLA and LA 
contents. Besides its cholesterol-lowering effects, it is so far the most
promising edible oil as a balanced source of EFAs for western-type diets. 
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APPENDIX
Trivial and systematic names for fatty acids in this study are listed below. 
The first double bond position in the carbon chain counting from the 
terminal methyl group is denoted by n-3, n-6, n-7, n-9 and n-12. 
Trivial name Systematic name Shorthand designation 
SaFAs
capric acid decanoic acid 10:0 
lauric acid dodecanoic acid 12:0 
myristic acid tetradecanoic acid 14:0 
palmitic acid hexadecanoic acid 16:0 
margaric acid heptadecanoic acid 17:0 
stearic acid octadecanoic acid 18:0 
arachidic acid eicosanoic acid 20:0 
behenic acid docosanoic acid 22:0 
lignoceric acid tetracosanoic acid 24:0 
MUFAs 
palmitoleic acid 9-hexadecenoic acid 16:1n-7 
oleic acid 9-octadecenoic acid 18:1n-9 
cis-vaccenic acid (asclepic acid) 11-octadecenoic acid 18:1n-7 
petroselinic acid 6-octadecenoic acid 18:1n-12
eicosenoic acid (gondoic acid) 11-eicosenoic acid 20:1n-9 
erucic acid 13-docosenoic acid 22:1n-9 
nervonic acid 15-tetracosenoic acid 24:1n-9 
18:1trans-fatty acid isomers 
elaidic acid  9trans-octadecenoic acid 18:1n-9trans
vaccenic acid  11trans-octadecenoic acid 18:1n-7trans
petroselaidic acid 6trans-octadecenoic acid 18:1n-12trans
n-6 PUFAs 
linoleic acid  9,12-octadecadienoic acid 18:2n-6 
γ-linolenic acid  6,9,12-octadecatrienoic acid 18:3n-6 
homo-γ-linolenic acid 8,11,14-eicosatrienoic acid 20:3n-6 
arachidonic acid 5,8,11,14-eicosatetraenoic acid 20:4n-6 
n-3 PUFAs 
α-linolenic acid  9,12,15-octadecatrienoic acid 18:3n-3 
stearidonic acid (moroctic acid) 6,9,12,15-octadecatetraenoic acid 18:4n-3 
eicosapentaenoic acid (timnodonic acid) 5,8,11,14,17-eicosapentaenoic acid 20:5n-3 
docosapentaenoic acid (clupanodonic acid) 7,10,13,16,19-docosapentaenoic acid 22:5n-3 
docosahexaenoic acid (cervonic acid) 4,7,10,13,16,19-docosahexaenoic acid 22:6n-3 
References: Lobb and Chow 2000; O'Keefe 1998.
